{
  "resourceType" : "StructureDefinition",
  "id" : "onco-azacitidine-questionnaire",
  "language" : "en",
  "text" : {
    "status" : "extensions",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: StructureDefinition onco-azacitidine-questionnaire</b></p><a name=\"onco-azacitidine-questionnaire\"> </a><a name=\"hconco-azacitidine-questionnaire\"> </a><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border: 0px #F0F0F0 solid; font-size: 11px; font-family: verdana; vertical-align: top;\"><tr style=\"border: 1px #F0F0F0 solid; font-size: 11px; font-family: verdana; vertical-align: top\"><th style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px; padding-top: 3px; padding-bottom: 3px\" class=\"hierarchy\"><a href=\"https://build.fhir.org/ig/FHIR/ig-guidance/readingIgs.html#table-views\" title=\"The logical name of the element\">Name</a></th><th style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px; padding-top: 3px; padding-bottom: 3px\" class=\"hierarchy\"><a href=\"https://build.fhir.org/ig/FHIR/ig-guidance/readingIgs.html#table-views\" title=\"Information about the use of the element\">Flags</a></th><th style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px; padding-top: 3px; padding-bottom: 3px\" class=\"hierarchy\"><a href=\"https://build.fhir.org/ig/FHIR/ig-guidance/readingIgs.html#table-views\" title=\"Minimum and Maximum # of times the element can appear in the instance\">Card.</a></th><th style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px; padding-top: 3px; padding-bottom: 3px; width: 100px\" class=\"hierarchy\"><a href=\"https://build.fhir.org/ig/FHIR/ig-guidance/readingIgs.html#table-views\" title=\"Reference to the type of the element\">Type</a></th><th style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px; padding-top: 3px; padding-bottom: 3px\" class=\"hierarchy\"><a href=\"https://build.fhir.org/ig/FHIR/ig-guidance/readingIgs.html#table-views\" title=\"Additional information about the element\">Description &amp; Constraints</a><span style=\"float: right\"><a href=\"https://build.fhir.org/ig/FHIR/ig-guidance/readingIgs.html#table-views\" title=\"Legend for this format\"><img src=\"data:image/png;base64,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\" alt=\"doco\" style=\"background-color: inherit\"/></a></span></th></tr><tr style=\"border: 0px #F0F0F0 solid; padding:0px; vertical-align: top; background-color: white\"><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px; white-space: nowrap; background-image: url(tbl_bck1.png)\" class=\"hierarchy\"><img src=\"tbl_spacer.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"icon_element.gif\" alt=\".\" style=\"background-color: white; background-color: inherit\" title=\"Element\" class=\"hierarchy\"/> <a href=\"StructureDefinition-onco-azacitidine-questionnaire-definitions.html#ONCOAzacitidineQuestionnaire\" title=\"Logical model representing the nursing assessment questionnaire for home hospitalization patients receiving Azacitidine. This questionnaire is filled in by the home nurse during each visit and exchanged as a FHIR QuestionnaireResponse with the hospital. Specific features: includes oxygen saturation (conditional, only when cough or shortness of breath), contraindications focused on GI symptoms and general deterioration, and a medication dissolution check.\">ONCOAzacitidineQuestionnaire</a><a name=\"ONCOAzacitidineQuestionnaire\"> </a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"/><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"><span style=\"opacity: 0.5\">0</span><span style=\"opacity: 0.5\">..</span><span style=\"opacity: 0.5\">*</span></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"><a href=\"http://build.fhir.org/types.html#Base\">Base</a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">ONCO Azacitidine Questionnaire Logical Model</td></tr>\r\n<tr style=\"border: 0px #F0F0F0 solid; padding:0px; vertical-align: top; background-color: #F7F7F7\"><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px; white-space: nowrap; background-image: url(tbl_bck01.png)\" class=\"hierarchy\"><img src=\"tbl_spacer.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vjoin_end.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"icon_datatype.gif\" alt=\".\" style=\"background-color: #F7F7F7; background-color: inherit\" title=\"Data Type\" class=\"hierarchy\"/> <a href=\"StructureDefinition-onco-azacitidine-questionnaire-definitions.html#ONCOAzacitidineQuestionnaire.nursingAssessment\" title=\"Nursing Assessment\">nursingAssessment</a><a name=\"ONCOAzacitidineQuestionnaire.nursingAssessment\"> </a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"/><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">1..1</td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"><a href=\"http://hl7.org/fhir/R4/datatypes.html#BackboneElement\">BackboneElement</a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">Nursing Assessment</td></tr>\r\n<tr style=\"border: 0px #F0F0F0 solid; padding:0px; vertical-align: top; background-color: white\"><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px; white-space: nowrap; background-image: url(tbl_bck011.png)\" class=\"hierarchy\"><img src=\"tbl_spacer.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_blank.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vjoin.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"icon_datatype.gif\" alt=\".\" style=\"background-color: white; background-color: inherit\" title=\"Data Type\" class=\"hierarchy\"/> <a href=\"StructureDefinition-onco-azacitidine-questionnaire-definitions.html#ONCOAzacitidineQuestionnaire.nursingAssessment.storage\" title=\"Storage\">storage</a><a name=\"ONCOAzacitidineQuestionnaire.nursingAssessment.storage\"> </a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"/><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">1..1</td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"><a href=\"http://hl7.org/fhir/R4/datatypes.html#BackboneElement\">BackboneElement</a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">Storage</td></tr>\r\n<tr style=\"border: 0px #F0F0F0 solid; padding:0px; vertical-align: top; background-color: #F7F7F7\"><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px; white-space: nowrap; background-image: url(tbl_bck0110.png)\" class=\"hierarchy\"><img src=\"tbl_spacer.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_blank.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vline.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vjoin.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"icon_primitive.png\" alt=\".\" style=\"background-color: #F7F7F7; background-color: inherit\" title=\"Primitive Data Type\" class=\"hierarchy\"/> <a href=\"StructureDefinition-onco-azacitidine-questionnaire-definitions.html#ONCOAzacitidineQuestionnaire.nursingAssessment.storage.medicationStorageRemarks\" title=\"Are there any remarks or concerns regarding the (proper) home storage of medication? (SNOMED 422413002) | Answers: 710977001 Medication stored correctly | 424363005 Concern about proper home storage\">medicationStorageRemarks</a><a name=\"ONCOAzacitidineQuestionnaire.nursingAssessment.storage.medicationStorageRemarks\"> </a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"/><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">1..1</td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"><a href=\"http://hl7.org/fhir/R4/datatypes.html#code\">code</a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">Are there any remarks or concerns regarding the (proper) home storage of medication? (SNOMED 422413002) | Answers: 710977001 Medication stored correctly | 424363005 Concern about proper home storage</td></tr>\r\n<tr style=\"border: 0px #F0F0F0 solid; padding:0px; vertical-align: top; background-color: white\"><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px; white-space: nowrap; background-image: url(tbl_bck0100.png)\" class=\"hierarchy\"><img src=\"tbl_spacer.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_blank.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vline.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vjoin_end.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"icon_primitive.png\" alt=\".\" style=\"background-color: white; background-color: inherit\" title=\"Primitive Data Type\" class=\"hierarchy\"/> <a href=\"StructureDefinition-onco-azacitidine-questionnaire-definitions.html#ONCOAzacitidineQuestionnaire.nursingAssessment.storage.storageRemarksSpecification\" title=\"Specify remarks or concerns (conditional: if medicationStorageRemarks = concern)\">storageRemarksSpecification</a><a name=\"ONCOAzacitidineQuestionnaire.nursingAssessment.storage.storageRemarksSpecification\"> </a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"/><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">0..1</td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"><a href=\"http://hl7.org/fhir/R4/datatypes.html#string\">string</a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">Specify remarks or concerns (conditional: if medicationStorageRemarks = concern)</td></tr>\r\n<tr style=\"border: 0px #F0F0F0 solid; padding:0px; vertical-align: top; background-color: #F7F7F7\"><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px; white-space: nowrap; background-image: url(tbl_bck011.png)\" class=\"hierarchy\"><img src=\"tbl_spacer.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_blank.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vjoin.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"icon_datatype.gif\" alt=\".\" style=\"background-color: #F7F7F7; background-color: inherit\" title=\"Data Type\" class=\"hierarchy\"/> <a href=\"StructureDefinition-onco-azacitidine-questionnaire-definitions.html#ONCOAzacitidineQuestionnaire.nursingAssessment.observationParameters\" title=\"Observation Parameters\">observationParameters</a><a name=\"ONCOAzacitidineQuestionnaire.nursingAssessment.observationParameters\"> </a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"/><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">1..1</td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"><a href=\"http://hl7.org/fhir/R4/datatypes.html#BackboneElement\">BackboneElement</a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">Observation Parameters</td></tr>\r\n<tr style=\"border: 0px #F0F0F0 solid; padding:0px; vertical-align: top; background-color: white\"><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px; white-space: nowrap; background-image: url(tbl_bck0110.png)\" class=\"hierarchy\"><img src=\"tbl_spacer.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_blank.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vline.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vjoin.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"icon_primitive.png\" alt=\".\" style=\"background-color: white; background-color: inherit\" title=\"Primitive Data Type\" class=\"hierarchy\"/> <a href=\"StructureDefinition-onco-azacitidine-questionnaire-definitions.html#ONCOAzacitidineQuestionnaire.nursingAssessment.observationParameters.bodyTemperature\" title=\"Body temperature (°C) (LOINC 8310-5)\">bodyTemperature</a><a name=\"ONCOAzacitidineQuestionnaire.nursingAssessment.observationParameters.bodyTemperature\"> </a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"/><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">1..1</td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"><a href=\"http://hl7.org/fhir/R4/datatypes.html#decimal\">decimal</a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">Body temperature (°C) (LOINC 8310-5)</td></tr>\r\n<tr style=\"border: 0px #F0F0F0 solid; padding:0px; vertical-align: top; background-color: #F7F7F7\"><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px; white-space: nowrap; background-image: url(tbl_bck0110.png)\" class=\"hierarchy\"><img src=\"tbl_spacer.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_blank.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vline.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vjoin.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"icon_primitive.png\" alt=\".\" style=\"background-color: #F7F7F7; background-color: inherit\" title=\"Primitive Data Type\" class=\"hierarchy\"/> <a href=\"StructureDefinition-onco-azacitidine-questionnaire-definitions.html#ONCOAzacitidineQuestionnaire.nursingAssessment.observationParameters.pulse\" title=\"Pulse (beats/min) (SNOMED 364075005)\">pulse</a><a name=\"ONCOAzacitidineQuestionnaire.nursingAssessment.observationParameters.pulse\"> </a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"/><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">1..1</td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"><a href=\"http://hl7.org/fhir/R4/datatypes.html#decimal\">decimal</a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">Pulse (beats/min) (SNOMED 364075005)</td></tr>\r\n<tr style=\"border: 0px #F0F0F0 solid; padding:0px; vertical-align: top; background-color: white\"><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px; white-space: nowrap; background-image: url(tbl_bck0110.png)\" class=\"hierarchy\"><img src=\"tbl_spacer.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_blank.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vline.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vjoin.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"icon_primitive.png\" alt=\".\" style=\"background-color: white; background-color: inherit\" title=\"Primitive Data Type\" class=\"hierarchy\"/> <a href=\"StructureDefinition-onco-azacitidine-questionnaire-definitions.html#ONCOAzacitidineQuestionnaire.nursingAssessment.observationParameters.bloodPressureSystolic\" title=\"Blood pressure systolic (mmHg) (LOINC 8480-6)\">bloodPressureSystolic</a><a name=\"ONCOAzacitidineQuestionnaire.nursingAssessment.observationParameters.bloodPressureSystolic\"> </a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"/><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">1..1</td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"><a href=\"http://hl7.org/fhir/R4/datatypes.html#decimal\">decimal</a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">Blood pressure systolic (mmHg) (LOINC 8480-6)</td></tr>\r\n<tr style=\"border: 0px #F0F0F0 solid; padding:0px; vertical-align: top; background-color: #F7F7F7\"><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px; white-space: nowrap; background-image: url(tbl_bck0110.png)\" class=\"hierarchy\"><img src=\"tbl_spacer.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_blank.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vline.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vjoin.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"icon_primitive.png\" alt=\".\" style=\"background-color: #F7F7F7; background-color: inherit\" title=\"Primitive Data Type\" class=\"hierarchy\"/> <a href=\"StructureDefinition-onco-azacitidine-questionnaire-definitions.html#ONCOAzacitidineQuestionnaire.nursingAssessment.observationParameters.bloodPressureDiastolic\" title=\"Blood pressure diastolic (mmHg) (LOINC 8462-4)\">bloodPressureDiastolic</a><a name=\"ONCOAzacitidineQuestionnaire.nursingAssessment.observationParameters.bloodPressureDiastolic\"> </a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"/><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">1..1</td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"><a href=\"http://hl7.org/fhir/R4/datatypes.html#decimal\">decimal</a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">Blood pressure diastolic (mmHg) (LOINC 8462-4)</td></tr>\r\n<tr style=\"border: 0px #F0F0F0 solid; padding:0px; vertical-align: top; background-color: white\"><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px; white-space: nowrap; background-image: url(tbl_bck0100.png)\" class=\"hierarchy\"><img src=\"tbl_spacer.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_blank.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vline.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vjoin_end.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"icon_primitive.png\" alt=\".\" style=\"background-color: white; background-color: inherit\" title=\"Primitive Data Type\" class=\"hierarchy\"/> <a href=\"StructureDefinition-onco-azacitidine-questionnaire-definitions.html#ONCOAzacitidineQuestionnaire.nursingAssessment.observationParameters.oxygenSaturation\" title=\"Oxygen saturation (%) (LOINC 2708-6) — Only measure if cough or shortness of breath is present\">oxygenSaturation</a><a name=\"ONCOAzacitidineQuestionnaire.nursingAssessment.observationParameters.oxygenSaturation\"> </a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"/><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">0..1</td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"><a href=\"http://hl7.org/fhir/R4/datatypes.html#decimal\">decimal</a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">Oxygen saturation (%) (LOINC 2708-6) — Only measure if cough or shortness of breath is present</td></tr>\r\n<tr style=\"border: 0px #F0F0F0 solid; padding:0px; vertical-align: top; background-color: #F7F7F7\"><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px; white-space: nowrap; background-image: url(tbl_bck011.png)\" class=\"hierarchy\"><img src=\"tbl_spacer.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_blank.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vjoin.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"icon_datatype.gif\" alt=\".\" style=\"background-color: #F7F7F7; background-color: inherit\" title=\"Data Type\" class=\"hierarchy\"/> <a href=\"StructureDefinition-onco-azacitidine-questionnaire-definitions.html#ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications\" title=\"Contraindications\">contraindications</a><a name=\"ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications\"> </a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"/><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">1..1</td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"><a href=\"http://hl7.org/fhir/R4/datatypes.html#BackboneElement\">BackboneElement</a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">Contraindications</td></tr>\r\n<tr style=\"border: 0px #F0F0F0 solid; padding:0px; vertical-align: top; background-color: white\"><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px; white-space: nowrap; background-image: url(tbl_bck0110.png)\" class=\"hierarchy\"><img src=\"tbl_spacer.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_blank.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vline.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vjoin.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"icon_primitive.png\" alt=\".\" style=\"background-color: white; background-color: inherit\" title=\"Primitive Data Type\" class=\"hierarchy\"/> <a href=\"StructureDefinition-onco-azacitidine-questionnaire-definitions.html#ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.anyContraindication\" title=\"Are there contraindications for administration? (SNOMED 395008009) | Answers: 373066001 Yes | 373067005 No\">anyContraindication</a><a name=\"ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.anyContraindication\"> </a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"/><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">1..1</td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"><a href=\"http://hl7.org/fhir/R4/datatypes.html#code\">code</a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">Are there contraindications for administration? (SNOMED 395008009) | Answers: 373066001 Yes | 373067005 No</td></tr>\r\n<tr style=\"border: 0px #F0F0F0 solid; padding:0px; vertical-align: top; background-color: #F7F7F7\"><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px; white-space: nowrap; background-image: url(tbl_bck0110.png)\" class=\"hierarchy\"><img src=\"tbl_spacer.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_blank.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vline.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vjoin.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"icon_primitive.png\" alt=\".\" style=\"background-color: #F7F7F7; background-color: inherit\" title=\"Primitive Data Type\" class=\"hierarchy\"/> <a href=\"StructureDefinition-onco-azacitidine-questionnaire-definitions.html#ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.feverChillsUnwell\" title=\"Fever, chills, feeling unwell (SNOMED 39104002) | Answers: 373066001 Yes | 373067005 No (conditional: if anyContraindication = Yes)\">feverChillsUnwell</a><a name=\"ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.feverChillsUnwell\"> </a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"/><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">0..1</td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"><a href=\"http://hl7.org/fhir/R4/datatypes.html#code\">code</a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">Fever, chills, feeling unwell (SNOMED 39104002) | Answers: 373066001 Yes | 373067005 No (conditional: if anyContraindication = Yes)</td></tr>\r\n<tr style=\"border: 0px #F0F0F0 solid; padding:0px; vertical-align: top; background-color: white\"><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px; white-space: nowrap; background-image: url(tbl_bck0110.png)\" class=\"hierarchy\"><img src=\"tbl_spacer.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_blank.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vline.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vjoin.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"icon_primitive.png\" alt=\".\" style=\"background-color: white; background-color: inherit\" title=\"Primitive Data Type\" class=\"hierarchy\"/> <a href=\"StructureDefinition-onco-azacitidine-questionnaire-definitions.html#ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.noOralIntake\" title=\"No oral intake due to reduced appetite or taste changes (SNOMED 247318005) | Answers: 373066001 Yes | 373067005 No\">noOralIntake</a><a name=\"ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.noOralIntake\"> </a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"/><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">0..1</td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"><a href=\"http://hl7.org/fhir/R4/datatypes.html#code\">code</a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">No oral intake due to reduced appetite or taste changes (SNOMED 247318005) | Answers: 373066001 Yes | 373067005 No</td></tr>\r\n<tr style=\"border: 0px #F0F0F0 solid; padding:0px; vertical-align: top; background-color: #F7F7F7\"><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px; white-space: nowrap; background-image: url(tbl_bck0110.png)\" class=\"hierarchy\"><img src=\"tbl_spacer.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_blank.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vline.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vjoin.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"icon_primitive.png\" alt=\".\" style=\"background-color: #F7F7F7; background-color: inherit\" title=\"Primitive Data Type\" class=\"hierarchy\"/> <a href=\"StructureDefinition-onco-azacitidine-questionnaire-definitions.html#ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.severeNausea\" title=\"Severe nausea (nausea with insufficient oral intake) (SNOMED 73335002) | Answers: 373066001 Yes | 373067005 No\">severeNausea</a><a name=\"ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.severeNausea\"> </a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"/><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">0..1</td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"><a href=\"http://hl7.org/fhir/R4/datatypes.html#code\">code</a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">Severe nausea (nausea with insufficient oral intake) (SNOMED 73335002) | Answers: 373066001 Yes | 373067005 No</td></tr>\r\n<tr style=\"border: 0px #F0F0F0 solid; padding:0px; vertical-align: top; background-color: white\"><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px; white-space: nowrap; background-image: url(tbl_bck0110.png)\" class=\"hierarchy\"><img src=\"tbl_spacer.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_blank.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vline.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vjoin.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"icon_primitive.png\" alt=\".\" style=\"background-color: white; background-color: inherit\" title=\"Primitive Data Type\" class=\"hierarchy\"/> <a href=\"StructureDefinition-onco-azacitidine-questionnaire-definitions.html#ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.increasedDyspnea\" title=\"Increased or severe shortness of breath (at rest or impacting daily activities) (SNOMED 297216006) | Answers: 373066001 Yes | 373067005 No\">increasedDyspnea</a><a name=\"ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.increasedDyspnea\"> </a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"/><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">0..1</td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"><a href=\"http://hl7.org/fhir/R4/datatypes.html#code\">code</a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">Increased or severe shortness of breath (at rest or impacting daily activities) (SNOMED 297216006) | Answers: 373066001 Yes | 373067005 No</td></tr>\r\n<tr style=\"border: 0px #F0F0F0 solid; padding:0px; vertical-align: top; background-color: #F7F7F7\"><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px; white-space: nowrap; background-image: url(tbl_bck0110.png)\" class=\"hierarchy\"><img src=\"tbl_spacer.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_blank.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vline.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vjoin.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"icon_primitive.png\" alt=\".\" style=\"background-color: #F7F7F7; background-color: inherit\" title=\"Primitive Data Type\" class=\"hierarchy\"/> <a href=\"StructureDefinition-onco-azacitidine-questionnaire-definitions.html#ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.newOrIncreasedCough\" title=\"New or increased productive/dry cough, with or without dyspnea (SNOMED 11833005) | Answers: 373066001 Yes | 373067005 No\">newOrIncreasedCough</a><a name=\"ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.newOrIncreasedCough\"> </a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"/><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">0..1</td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"><a href=\"http://hl7.org/fhir/R4/datatypes.html#code\">code</a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">New or increased productive/dry cough, with or without dyspnea (SNOMED 11833005) | Answers: 373066001 Yes | 373067005 No</td></tr>\r\n<tr style=\"border: 0px #F0F0F0 solid; padding:0px; vertical-align: top; background-color: white\"><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px; white-space: nowrap; background-image: url(tbl_bck0110.png)\" class=\"hierarchy\"><img src=\"tbl_spacer.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_blank.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vline.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vjoin.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"icon_primitive.png\" alt=\".\" style=\"background-color: white; background-color: inherit\" title=\"Primitive Data Type\" class=\"hierarchy\"/> <a href=\"StructureDefinition-onco-azacitidine-questionnaire-definitions.html#ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.generalDeterioration\" title=\"General deterioration (SNOMED 154091000119106) | Answers: 373066001 Yes | 373067005 No\">generalDeterioration</a><a name=\"ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.generalDeterioration\"> </a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"/><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">0..1</td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"><a href=\"http://hl7.org/fhir/R4/datatypes.html#code\">code</a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">General deterioration (SNOMED 154091000119106) | Answers: 373066001 Yes | 373067005 No</td></tr>\r\n<tr style=\"border: 0px #F0F0F0 solid; padding:0px; vertical-align: top; background-color: #F7F7F7\"><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px; white-space: nowrap; background-image: url(tbl_bck0110.png)\" class=\"hierarchy\"><img src=\"tbl_spacer.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_blank.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vline.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vjoin.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"icon_primitive.png\" alt=\".\" style=\"background-color: #F7F7F7; background-color: inherit\" title=\"Primitive Data Type\" class=\"hierarchy\"/> <a href=\"StructureDefinition-onco-azacitidine-questionnaire-definitions.html#ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.decisionAfterConsultation\" title=\"Decision after consultation with hospital (SNOMED 182836005) | Answers: Administration | No administration | Other\">decisionAfterConsultation</a><a name=\"ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.decisionAfterConsultation\"> </a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"/><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">0..1</td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"><a href=\"http://hl7.org/fhir/R4/datatypes.html#code\">code</a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">Decision after consultation with hospital (SNOMED 182836005) | Answers: Administration | No administration | Other</td></tr>\r\n<tr style=\"border: 0px #F0F0F0 solid; padding:0px; vertical-align: top; background-color: white\"><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px; white-space: nowrap; background-image: url(tbl_bck0100.png)\" class=\"hierarchy\"><img src=\"tbl_spacer.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_blank.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vline.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vjoin_end.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"icon_primitive.png\" alt=\".\" style=\"background-color: white; background-color: inherit\" title=\"Primitive Data Type\" class=\"hierarchy\"/> <a href=\"StructureDefinition-onco-azacitidine-questionnaire-definitions.html#ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.decisionOtherSpecification\" title=\"Specify if decision = Other (SNOMED 438833006)\">decisionOtherSpecification</a><a name=\"ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.decisionOtherSpecification\"> </a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"/><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">0..1</td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"><a href=\"http://hl7.org/fhir/R4/datatypes.html#string\">string</a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">Specify if decision = Other (SNOMED 438833006)</td></tr>\r\n<tr style=\"border: 0px #F0F0F0 solid; padding:0px; vertical-align: top; background-color: #F7F7F7\"><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px; white-space: nowrap; background-image: url(tbl_bck011.png)\" class=\"hierarchy\"><img src=\"tbl_spacer.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_blank.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vjoin.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"icon_datatype.gif\" alt=\".\" style=\"background-color: #F7F7F7; background-color: inherit\" title=\"Data Type\" class=\"hierarchy\"/> <a href=\"StructureDefinition-onco-azacitidine-questionnaire-definitions.html#ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden\" title=\"Symptom Burden\">symptomBurden</a><a name=\"ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden\"> </a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"/><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">1..1</td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"><a href=\"http://hl7.org/fhir/R4/datatypes.html#BackboneElement\">BackboneElement</a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">Symptom Burden</td></tr>\r\n<tr style=\"border: 0px #F0F0F0 solid; padding:0px; vertical-align: top; background-color: white\"><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px; white-space: nowrap; background-image: url(tbl_bck0110.png)\" class=\"hierarchy\"><img src=\"tbl_spacer.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_blank.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vline.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vjoin.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"icon_primitive.png\" alt=\".\" style=\"background-color: white; background-color: inherit\" title=\"Primitive Data Type\" class=\"hierarchy\"/> <a href=\"StructureDefinition-onco-azacitidine-questionnaire-definitions.html#ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.nausea\" title=\"Nausea (SNOMED 422587007) | Answers: 444431007 Grade 0 (None) | 444456001 Grade 1 | 444457005 Grade 2 | 444447009 Grade 3\">nausea</a><a name=\"ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.nausea\"> </a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"/><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">1..1</td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"><a href=\"http://hl7.org/fhir/R4/datatypes.html#code\">code</a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">Nausea (SNOMED 422587007) | Answers: 444431007 Grade 0 (None) | 444456001 Grade 1 | 444457005 Grade 2 | 444447009 Grade 3</td></tr>\r\n<tr style=\"border: 0px #F0F0F0 solid; padding:0px; vertical-align: top; background-color: #F7F7F7\"><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px; white-space: nowrap; background-image: url(tbl_bck0110.png)\" class=\"hierarchy\"><img src=\"tbl_spacer.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_blank.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vline.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vjoin.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"icon_primitive.png\" alt=\".\" style=\"background-color: #F7F7F7; background-color: inherit\" title=\"Primitive Data Type\" class=\"hierarchy\"/> <a href=\"StructureDefinition-onco-azacitidine-questionnaire-definitions.html#ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.vomiting\" title=\"Vomiting (SNOMED 249497008) | Answers: 444431007 Grade 0 | 444456001 Grade 1 (&lt;=2 times) | 444457005 Grade 2 (3-5 times) | 444447009 Grade 3 (6+ times)\">vomiting</a><a name=\"ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.vomiting\"> </a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"/><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">1..1</td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"><a href=\"http://hl7.org/fhir/R4/datatypes.html#code\">code</a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">Vomiting (SNOMED 249497008) | Answers: 444431007 Grade 0 | 444456001 Grade 1 (&lt;=2 times) | 444457005 Grade 2 (3-5 times) | 444447009 Grade 3 (6+ times)</td></tr>\r\n<tr style=\"border: 0px #F0F0F0 solid; padding:0px; vertical-align: top; background-color: white\"><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px; white-space: nowrap; background-image: url(tbl_bck0110.png)\" class=\"hierarchy\"><img src=\"tbl_spacer.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_blank.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vline.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vjoin.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"icon_primitive.png\" alt=\".\" style=\"background-color: white; background-color: inherit\" title=\"Primitive Data Type\" class=\"hierarchy\"/> <a href=\"StructureDefinition-onco-azacitidine-questionnaire-definitions.html#ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.reducedAppetiteOrTasteChanges\" title=\"Reduced appetite or taste changes (SNOMED 64379006) | Answers: 444431007 Grade 0 | 444456001 Grade 1 | 444457005 Grade 2 | 444447009 Grade 3\">reducedAppetiteOrTasteChanges</a><a name=\"ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.reducedAppetiteOrTasteChanges\"> </a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"/><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">1..1</td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"><a href=\"http://hl7.org/fhir/R4/datatypes.html#code\">code</a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">Reduced appetite or taste changes (SNOMED 64379006) | Answers: 444431007 Grade 0 | 444456001 Grade 1 | 444457005 Grade 2 | 444447009 Grade 3</td></tr>\r\n<tr style=\"border: 0px #F0F0F0 solid; padding:0px; vertical-align: top; background-color: #F7F7F7\"><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px; white-space: nowrap; background-image: url(tbl_bck0110.png)\" class=\"hierarchy\"><img src=\"tbl_spacer.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_blank.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vline.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vjoin.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"icon_primitive.png\" alt=\".\" style=\"background-color: #F7F7F7; background-color: inherit\" title=\"Primitive Data Type\" class=\"hierarchy\"/> <a href=\"StructureDefinition-onco-azacitidine-questionnaire-definitions.html#ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.diarrhea\" title=\"Diarrhea (SNOMED 62315008) | Answers: 444431007 Grade 0 | 444456001 Grade 1 (1-3x more) | 444457005 Grade 2 (4-6x more) | 444447009 Grade 3 (&gt;6x or impacting daily life)\">diarrhea</a><a name=\"ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.diarrhea\"> </a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"/><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">1..1</td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"><a href=\"http://hl7.org/fhir/R4/datatypes.html#code\">code</a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">Diarrhea (SNOMED 62315008) | Answers: 444431007 Grade 0 | 444456001 Grade 1 (1-3x more) | 444457005 Grade 2 (4-6x more) | 444447009 Grade 3 (&gt;6x or impacting daily life)</td></tr>\r\n<tr style=\"border: 0px #F0F0F0 solid; padding:0px; vertical-align: top; background-color: white\"><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px; white-space: nowrap; background-image: url(tbl_bck0110.png)\" class=\"hierarchy\"><img src=\"tbl_spacer.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_blank.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vline.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vjoin.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"icon_primitive.png\" alt=\".\" style=\"background-color: white; background-color: inherit\" title=\"Primitive Data Type\" class=\"hierarchy\"/> <a href=\"StructureDefinition-onco-azacitidine-questionnaire-definitions.html#ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.constipation\" title=\"Constipation (SNOMED 14760008) | Answers: 444431007 Grade 0 | 444456001 Grade 1 | 444457005 Grade 2 | 444447009 Grade 3\">constipation</a><a name=\"ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.constipation\"> </a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"/><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">1..1</td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"><a href=\"http://hl7.org/fhir/R4/datatypes.html#code\">code</a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">Constipation (SNOMED 14760008) | Answers: 444431007 Grade 0 | 444456001 Grade 1 | 444457005 Grade 2 | 444447009 Grade 3</td></tr>\r\n<tr style=\"border: 0px #F0F0F0 solid; padding:0px; vertical-align: top; background-color: #F7F7F7\"><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px; white-space: nowrap; background-image: url(tbl_bck0110.png)\" class=\"hierarchy\"><img src=\"tbl_spacer.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_blank.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vline.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vjoin.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"icon_primitive.png\" alt=\".\" style=\"background-color: #F7F7F7; background-color: inherit\" title=\"Primitive Data Type\" class=\"hierarchy\"/> <a href=\"StructureDefinition-onco-azacitidine-questionnaire-definitions.html#ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.fatigue\" title=\"Fatigue / lack of energy (SNOMED 224960004) | Answers: 444431007 Grade 0 | 444456001 Grade 1 (mild) | 444457005 Grade 2 (moderate) | 444447009 Grade 3 (severe)\">fatigue</a><a name=\"ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.fatigue\"> </a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"/><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">1..1</td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"><a href=\"http://hl7.org/fhir/R4/datatypes.html#code\">code</a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">Fatigue / lack of energy (SNOMED 224960004) | Answers: 444431007 Grade 0 | 444456001 Grade 1 (mild) | 444457005 Grade 2 (moderate) | 444447009 Grade 3 (severe)</td></tr>\r\n<tr style=\"border: 0px #F0F0F0 solid; padding:0px; vertical-align: top; background-color: white\"><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px; white-space: nowrap; background-image: url(tbl_bck0110.png)\" class=\"hierarchy\"><img src=\"tbl_spacer.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_blank.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vline.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vjoin.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"icon_primitive.png\" alt=\".\" style=\"background-color: white; background-color: inherit\" title=\"Primitive Data Type\" class=\"hierarchy\"/> <a href=\"StructureDefinition-onco-azacitidine-questionnaire-definitions.html#ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.pain\" title=\"Pain (SNOMED 112104007) | Answers: 444431007 Grade 0 | 444456001 Grade 1 (mild) | 444457005 Grade 2 (moderate) | 444447009 Grade 3 (severe)\">pain</a><a name=\"ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.pain\"> </a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"/><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">1..1</td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"><a href=\"http://hl7.org/fhir/R4/datatypes.html#code\">code</a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">Pain (SNOMED 112104007) | Answers: 444431007 Grade 0 | 444456001 Grade 1 (mild) | 444457005 Grade 2 (moderate) | 444447009 Grade 3 (severe)</td></tr>\r\n<tr style=\"border: 0px #F0F0F0 solid; padding:0px; vertical-align: top; background-color: #F7F7F7\"><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px; white-space: nowrap; background-image: url(tbl_bck0110.png)\" class=\"hierarchy\"><img src=\"tbl_spacer.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_blank.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vline.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vjoin.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"icon_primitive.png\" alt=\".\" style=\"background-color: #F7F7F7; background-color: inherit\" title=\"Primitive Data Type\" class=\"hierarchy\"/> <a href=\"StructureDefinition-onco-azacitidine-questionnaire-definitions.html#ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.skinRash\" title=\"Skin rash (SNOMED 271807003) | Answers: 444431007 Grade 0 | 444456001 Grade 1 (limited redness) | 444457005 Grade 2 (moderate redness) | 444447009 Grade 3 (severe/extensive redness or peeling)\">skinRash</a><a name=\"ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.skinRash\"> </a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"/><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">1..1</td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"><a href=\"http://hl7.org/fhir/R4/datatypes.html#code\">code</a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">Skin rash (SNOMED 271807003) | Answers: 444431007 Grade 0 | 444456001 Grade 1 (limited redness) | 444457005 Grade 2 (moderate redness) | 444447009 Grade 3 (severe/extensive redness or peeling)</td></tr>\r\n<tr style=\"border: 0px #F0F0F0 solid; padding:0px; vertical-align: top; background-color: white\"><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px; white-space: nowrap; background-image: url(tbl_bck0110.png)\" class=\"hierarchy\"><img src=\"tbl_spacer.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_blank.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vline.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vjoin.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"icon_primitive.png\" alt=\".\" style=\"background-color: white; background-color: inherit\" title=\"Primitive Data Type\" class=\"hierarchy\"/> <a href=\"StructureDefinition-onco-azacitidine-questionnaire-definitions.html#ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.psychosocialBurden\" title=\"Psychosocial burden (SNOMED 384821006) | Answers: 444431007 Grade 0 (Feels well) | 444456001 Grade 1 (mild distress) | 444457005 Grade 2 (moderate impact) | 444447009 Grade 3 (severe impact)\">psychosocialBurden</a><a name=\"ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.psychosocialBurden\"> </a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"/><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">1..1</td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"><a href=\"http://hl7.org/fhir/R4/datatypes.html#code\">code</a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">Psychosocial burden (SNOMED 384821006) | Answers: 444431007 Grade 0 (Feels well) | 444456001 Grade 1 (mild distress) | 444457005 Grade 2 (moderate impact) | 444447009 Grade 3 (severe impact)</td></tr>\r\n<tr style=\"border: 0px #F0F0F0 solid; padding:0px; vertical-align: top; background-color: #F7F7F7\"><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px; white-space: nowrap; background-image: url(tbl_bck0110.png)\" class=\"hierarchy\"><img src=\"tbl_spacer.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_blank.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vline.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vjoin.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"icon_primitive.png\" alt=\".\" style=\"background-color: #F7F7F7; background-color: inherit\" title=\"Primitive Data Type\" class=\"hierarchy\"/> <a href=\"StructureDefinition-onco-azacitidine-questionnaire-definitions.html#ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.shortnessOfBreath\" title=\"Shortness of breath (SNOMED 267036007) | Answers: 444431007 Grade 0 | 444456001 Grade 1 (moderate exertion only) | 444457005 Grade 2 (light exertion affecting daily activities) | 444447009 Grade 3 (at rest affecting daily activities)\">shortnessOfBreath</a><a name=\"ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.shortnessOfBreath\"> </a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"/><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">1..1</td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"><a href=\"http://hl7.org/fhir/R4/datatypes.html#code\">code</a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">Shortness of breath (SNOMED 267036007) | Answers: 444431007 Grade 0 | 444456001 Grade 1 (moderate exertion only) | 444457005 Grade 2 (light exertion affecting daily activities) | 444447009 Grade 3 (at rest affecting daily activities)</td></tr>\r\n<tr style=\"border: 0px #F0F0F0 solid; padding:0px; vertical-align: top; background-color: white\"><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px; white-space: nowrap; background-image: url(tbl_bck0100.png)\" class=\"hierarchy\"><img src=\"tbl_spacer.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_blank.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vline.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vjoin_end.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"icon_primitive.png\" alt=\".\" style=\"background-color: white; background-color: inherit\" title=\"Primitive Data Type\" class=\"hierarchy\"/> <a href=\"StructureDefinition-onco-azacitidine-questionnaire-definitions.html#ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.cough\" title=\"Cough (SNOMED 49727002) | Answers: 444431007 Grade 0 | 444456001 Grade 1 (mild) | 444457005 Grade 2 (moderate) | 444447009 Grade 3 (severe)\">cough</a><a name=\"ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.cough\"> </a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"/><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">1..1</td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"><a href=\"http://hl7.org/fhir/R4/datatypes.html#code\">code</a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">Cough (SNOMED 49727002) | Answers: 444431007 Grade 0 | 444456001 Grade 1 (mild) | 444457005 Grade 2 (moderate) | 444447009 Grade 3 (severe)</td></tr>\r\n<tr style=\"border: 0px #F0F0F0 solid; padding:0px; vertical-align: top; background-color: #F7F7F7\"><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px; white-space: nowrap; background-image: url(tbl_bck011.png)\" class=\"hierarchy\"><img src=\"tbl_spacer.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_blank.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vjoin.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"icon_datatype.gif\" alt=\".\" style=\"background-color: #F7F7F7; background-color: inherit\" title=\"Data Type\" class=\"hierarchy\"/> <a href=\"StructureDefinition-onco-azacitidine-questionnaire-definitions.html#ONCOAzacitidineQuestionnaire.nursingAssessment.otherRelevantObservations\" title=\"Other Relevant Observations\">otherRelevantObservations</a><a name=\"ONCOAzacitidineQuestionnaire.nursingAssessment.otherRelevantObservations\"> </a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"/><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">0..1</td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"><a href=\"http://hl7.org/fhir/R4/datatypes.html#BackboneElement\">BackboneElement</a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">Other Relevant Observations</td></tr>\r\n<tr style=\"border: 0px #F0F0F0 solid; padding:0px; vertical-align: top; background-color: white\"><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px; white-space: nowrap; background-image: url(tbl_bck0100.png)\" class=\"hierarchy\"><img src=\"tbl_spacer.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_blank.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vline.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vjoin_end.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"icon_primitive.png\" alt=\".\" style=\"background-color: white; background-color: inherit\" title=\"Primitive Data Type\" class=\"hierarchy\"/> <a href=\"StructureDefinition-onco-azacitidine-questionnaire-definitions.html#ONCOAzacitidineQuestionnaire.nursingAssessment.otherRelevantObservations.otherObservations\" title=\"Other side effects or relevant clinical and psychosocial observations. Contact hospital in case of clinical concern. (SNOMED 365275006)\">otherObservations</a><a name=\"ONCOAzacitidineQuestionnaire.nursingAssessment.otherRelevantObservations.otherObservations\"> </a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"/><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">0..1</td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"><a href=\"http://hl7.org/fhir/R4/datatypes.html#string\">string</a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">Other side effects or relevant clinical and psychosocial observations. Contact hospital in case of clinical concern. (SNOMED 365275006)</td></tr>\r\n<tr style=\"border: 0px #F0F0F0 solid; padding:0px; vertical-align: top; background-color: #F7F7F7\"><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px; white-space: nowrap; background-image: url(tbl_bck011.png)\" class=\"hierarchy\"><img src=\"tbl_spacer.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_blank.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vjoin.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"icon_datatype.gif\" alt=\".\" style=\"background-color: #F7F7F7; background-color: inherit\" title=\"Data Type\" class=\"hierarchy\"/> <a href=\"StructureDefinition-onco-azacitidine-questionnaire-definitions.html#ONCOAzacitidineQuestionnaire.nursingAssessment.task\" title=\"Task\">task</a><a name=\"ONCOAzacitidineQuestionnaire.nursingAssessment.task\"> </a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"/><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">1..1</td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"><a href=\"http://hl7.org/fhir/R4/datatypes.html#BackboneElement\">BackboneElement</a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">Task</td></tr>\r\n<tr style=\"border: 0px #F0F0F0 solid; padding:0px; vertical-align: top; background-color: white\"><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px; white-space: nowrap; background-image: url(tbl_bck0110.png)\" class=\"hierarchy\"><img src=\"tbl_spacer.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_blank.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vline.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vjoin.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"icon_primitive.png\" alt=\".\" style=\"background-color: white; background-color: inherit\" title=\"Primitive Data Type\" class=\"hierarchy\"/> <a href=\"StructureDefinition-onco-azacitidine-questionnaire-definitions.html#ONCOAzacitidineQuestionnaire.nursingAssessment.task.medicationDissolvedClear\" title=\"Medication was completely dissolved into a clear solution without visible particles (SNOMED 396076000) | Answers: 373066001 Yes | 373067005 No\">medicationDissolvedClear</a><a name=\"ONCOAzacitidineQuestionnaire.nursingAssessment.task.medicationDissolvedClear\"> </a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"/><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">1..1</td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"><a href=\"http://hl7.org/fhir/R4/datatypes.html#code\">code</a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">Medication was completely dissolved into a clear solution without visible particles (SNOMED 396076000) | Answers: 373066001 Yes | 373067005 No</td></tr>\r\n<tr style=\"border: 0px #F0F0F0 solid; padding:0px; vertical-align: top; background-color: #F7F7F7\"><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px; white-space: nowrap; background-image: url(tbl_bck0100.png)\" class=\"hierarchy\"><img src=\"tbl_spacer.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_blank.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vline.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vjoin_end.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"icon_primitive.png\" alt=\".\" style=\"background-color: #F7F7F7; background-color: inherit\" title=\"Primitive Data Type\" class=\"hierarchy\"/> <a href=\"StructureDefinition-onco-azacitidine-questionnaire-definitions.html#ONCOAzacitidineQuestionnaire.nursingAssessment.task.medicationAdministeredPerProcedure\" title=\"Could the medication be administered exactly according to the procedure (no deviations)? (SNOMED 373149000) | Answers: 373066001 Yes | 373067005 No\">medicationAdministeredPerProcedure</a><a name=\"ONCOAzacitidineQuestionnaire.nursingAssessment.task.medicationAdministeredPerProcedure\"> </a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"/><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">1..1</td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"><a href=\"http://hl7.org/fhir/R4/datatypes.html#code\">code</a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">Could the medication be administered exactly according to the procedure (no deviations)? (SNOMED 373149000) | Answers: 373066001 Yes | 373067005 No</td></tr>\r\n<tr style=\"border: 0px #F0F0F0 solid; padding:0px; vertical-align: top; background-color: white\"><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px; white-space: nowrap; background-image: url(tbl_bck001.png)\" class=\"hierarchy\"><img src=\"tbl_spacer.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_blank.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vjoin_end.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"icon_datatype.gif\" alt=\".\" style=\"background-color: white; background-color: inherit\" title=\"Data Type\" class=\"hierarchy\"/> <a href=\"StructureDefinition-onco-azacitidine-questionnaire-definitions.html#ONCOAzacitidineQuestionnaire.nursingAssessment.qualityFollowUp\" title=\"Quality Follow-Up\">qualityFollowUp</a><a name=\"ONCOAzacitidineQuestionnaire.nursingAssessment.qualityFollowUp\"> </a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"/><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">0..1</td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"><a href=\"http://hl7.org/fhir/R4/datatypes.html#BackboneElement\">BackboneElement</a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: white; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">Quality Follow-Up</td></tr>\r\n<tr style=\"border: 0px #F0F0F0 solid; padding:0px; vertical-align: top; background-color: #F7F7F7\"><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px; white-space: nowrap; background-image: url(tbl_bck0000.png)\" class=\"hierarchy\"><img src=\"tbl_spacer.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_blank.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_blank.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"tbl_vjoin_end.png\" alt=\".\" style=\"background-color: inherit\" class=\"hierarchy\"/><img src=\"icon_primitive.png\" alt=\".\" style=\"background-color: #F7F7F7; background-color: inherit\" title=\"Primitive Data Type\" class=\"hierarchy\"/> <a href=\"StructureDefinition-onco-azacitidine-questionnaire-definitions.html#ONCOAzacitidineQuestionnaire.nursingAssessment.qualityFollowUp.remarks\" title=\"Remarks or concerns about patient registration, data sharing, hospital communication, material availability, or other transmural collaboration aspects (SNOMED 276238005)\">remarks</a><a name=\"ONCOAzacitidineQuestionnaire.nursingAssessment.qualityFollowUp.remarks\"> </a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"/><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">0..1</td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\"><a href=\"http://hl7.org/fhir/R4/datatypes.html#string\">string</a></td><td style=\"vertical-align: top; text-align : var(--ig-left,left); background-color: #F7F7F7; border: 0px #F0F0F0 solid; padding:0px 4px 0px 4px\" class=\"hierarchy\">Remarks or concerns about patient registration, data sharing, hospital communication, material availability, or other transmural collaboration aspects (SNOMED 276238005)</td></tr>\r\n<tr><td colspan=\"5\" class=\"hierarchy\"><br/><a href=\"https://build.fhir.org/ig/FHIR/ig-guidance/readingIgs.html#table-views\" title=\"Legend for this format\"><img src=\"data:image/png;base64,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\" alt=\"doco\" style=\"background-color: inherit\"/> Documentation for this format</a></td></tr></table></div>"
  },
  "url" : "http://hl7belgium.org/fhir/patient-monitoring/StructureDefinition/onco-azacitidine-questionnaire",
  "identifier" : [{
    "system" : "urn:ietf:rfc:3986",
    "value" : "urn:oid:2.16.840.1.113883.4.642.40.54.42.15"
  }],
  "version" : "0.1.0",
  "name" : "ONCOAzacitidineQuestionnaire",
  "title" : "ONCO Azacitidine Questionnaire Logical Model",
  "status" : "draft",
  "date" : "2026-05-18T17:09:55+00:00",
  "publisher" : "HL7 Belgium",
  "contact" : [{
    "name" : "HL7 Belgium",
    "telecom" : [{
      "system" : "url",
      "value" : "http://example.com/committees"
    },
    {
      "system" : "email",
      "value" : "my-group@example.com"
    }]
  },
  {
    "name" : "Bob Smith",
    "telecom" : [{
      "system" : "email",
      "value" : "bobsmith@example.com",
      "use" : "work"
    }]
  }],
  "description" : "Logical model representing the nursing assessment questionnaire for home hospitalization patients receiving Azacitidine. This questionnaire is filled in by the home nurse during each visit and exchanged as a FHIR QuestionnaireResponse with the hospital. Specific features: includes oxygen saturation (conditional, only when cough or shortness of breath), contraindications focused on GI symptoms and general deterioration, and a medication dissolution check.",
  "jurisdiction" : [{
    "coding" : [{
      "system" : "urn:iso:std:iso:3166",
      "code" : "BE",
      "display" : "Belgium"
    }]
  }],
  "fhirVersion" : "4.0.1",
  "kind" : "logical",
  "abstract" : false,
  "type" : "http://hl7belgium.org/fhir/patient-monitoring/StructureDefinition/ONCOAzacitidineQuestionnaire",
  "baseDefinition" : "http://hl7.org/fhir/StructureDefinition/Base",
  "derivation" : "specialization",
  "snapshot" : {
    "extension" : [{
      "url" : "http://hl7.org/fhir/tools/StructureDefinition/snapshot-base-version",
      "valueString" : "4.0.1"
    }],
    "element" : [{
      "id" : "ONCOAzacitidineQuestionnaire",
      "path" : "ONCOAzacitidineQuestionnaire",
      "short" : "ONCO Azacitidine Questionnaire Logical Model",
      "definition" : "Logical model representing the nursing assessment questionnaire for home hospitalization patients receiving Azacitidine. This questionnaire is filled in by the home nurse during each visit and exchanged as a FHIR QuestionnaireResponse with the hospital. Specific features: includes oxygen saturation (conditional, only when cough or shortness of breath), contraindications focused on GI symptoms and general deterioration, and a medication dissolution check.",
      "min" : 0,
      "max" : "*",
      "base" : {
        "path" : "Base",
        "min" : 0,
        "max" : "*"
      },
      "isModifier" : false
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment",
      "short" : "Nursing Assessment",
      "definition" : "Nursing Assessment",
      "min" : 1,
      "max" : "1",
      "base" : {
        "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment",
        "min" : 1,
        "max" : "1"
      },
      "type" : [{
        "code" : "BackboneElement"
      }],
      "constraint" : [{
        "key" : "ele-1",
        "severity" : "error",
        "human" : "All FHIR elements must have a @value or children",
        "expression" : "hasValue() or (children().count() > id.count())",
        "xpath" : "@value|f:*|h:div",
        "source" : "http://hl7.org/fhir/StructureDefinition/Element"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.id",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.id",
      "representation" : ["xmlAttr"],
      "short" : "Unique id for inter-element referencing",
      "definition" : "Unique id for the element within a resource (for internal references). This may be any string value that does not contain spaces.",
      "min" : 0,
      "max" : "1",
      "base" : {
        "path" : "Element.id",
        "min" : 0,
        "max" : "1"
      },
      "type" : [{
        "extension" : [{
          "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-fhir-type",
          "valueUrl" : "string"
        }],
        "code" : "http://hl7.org/fhirpath/System.String"
      }],
      "isModifier" : false,
      "isSummary" : false,
      "mapping" : [{
        "identity" : "rim",
        "map" : "n/a"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.extension",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.extension",
      "slicing" : {
        "discriminator" : [{
          "type" : "value",
          "path" : "url"
        }],
        "description" : "Extensions are always sliced by (at least) url",
        "rules" : "open"
      },
      "short" : "Additional content defined by implementations",
      "definition" : "May be used to represent additional information that is not part of the basic definition of the element. To make the use of extensions safe and manageable, there is a strict set of governance  applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension.",
      "comment" : "There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions.  The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.",
      "alias" : ["extensions",
      "user content"],
      "min" : 0,
      "max" : "*",
      "base" : {
        "path" : "Element.extension",
        "min" : 0,
        "max" : "*"
      },
      "type" : [{
        "code" : "Extension"
      }],
      "constraint" : [{
        "key" : "ele-1",
        "severity" : "error",
        "human" : "All FHIR elements must have a @value or children",
        "expression" : "hasValue() or (children().count() > id.count())",
        "xpath" : "@value|f:*|h:div",
        "source" : "http://hl7.org/fhir/StructureDefinition/Element"
      },
      {
        "key" : "ext-1",
        "severity" : "error",
        "human" : "Must have either extensions or value[x], not both",
        "expression" : "extension.exists() != value.exists()",
        "xpath" : "exists(f:extension)!=exists(f:*[starts-with(local-name(.), \"value\")])",
        "source" : "http://hl7.org/fhir/StructureDefinition/Extension"
      }],
      "isModifier" : false,
      "isSummary" : false,
      "mapping" : [{
        "identity" : "rim",
        "map" : "n/a"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.modifierExtension",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.modifierExtension",
      "short" : "Extensions that cannot be ignored even if unrecognized",
      "definition" : "May be used to represent additional information that is not part of the basic definition of the element and that modifies the understanding of the element in which it is contained and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions.\n\nModifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself).",
      "comment" : "There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions.  The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.",
      "requirements" : "Modifier extensions allow for extensions that *cannot* be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored.  This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the [definition of modifier extensions](http://hl7.org/fhir/R4/extensibility.html#modifierExtension).",
      "alias" : ["extensions",
      "user content",
      "modifiers"],
      "min" : 0,
      "max" : "*",
      "base" : {
        "path" : "BackboneElement.modifierExtension",
        "min" : 0,
        "max" : "*"
      },
      "type" : [{
        "code" : "Extension"
      }],
      "constraint" : [{
        "key" : "ele-1",
        "severity" : "error",
        "human" : "All FHIR elements must have a @value or children",
        "expression" : "hasValue() or (children().count() > id.count())",
        "xpath" : "@value|f:*|h:div",
        "source" : "http://hl7.org/fhir/StructureDefinition/Element"
      },
      {
        "key" : "ext-1",
        "severity" : "error",
        "human" : "Must have either extensions or value[x], not both",
        "expression" : "extension.exists() != value.exists()",
        "xpath" : "exists(f:extension)!=exists(f:*[starts-with(local-name(.), \"value\")])",
        "source" : "http://hl7.org/fhir/StructureDefinition/Extension"
      }],
      "isModifier" : true,
      "isModifierReason" : "Modifier extensions are expected to modify the meaning or interpretation of the element that contains them",
      "isSummary" : true,
      "mapping" : [{
        "identity" : "rim",
        "map" : "N/A"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.storage",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.storage",
      "short" : "Storage",
      "definition" : "Storage",
      "min" : 1,
      "max" : "1",
      "base" : {
        "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.storage",
        "min" : 1,
        "max" : "1"
      },
      "type" : [{
        "code" : "BackboneElement"
      }],
      "constraint" : [{
        "key" : "ele-1",
        "severity" : "error",
        "human" : "All FHIR elements must have a @value or children",
        "expression" : "hasValue() or (children().count() > id.count())",
        "xpath" : "@value|f:*|h:div",
        "source" : "http://hl7.org/fhir/StructureDefinition/Element"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.storage.id",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.storage.id",
      "representation" : ["xmlAttr"],
      "short" : "Unique id for inter-element referencing",
      "definition" : "Unique id for the element within a resource (for internal references). This may be any string value that does not contain spaces.",
      "min" : 0,
      "max" : "1",
      "base" : {
        "path" : "Element.id",
        "min" : 0,
        "max" : "1"
      },
      "type" : [{
        "extension" : [{
          "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-fhir-type",
          "valueUrl" : "string"
        }],
        "code" : "http://hl7.org/fhirpath/System.String"
      }],
      "isModifier" : false,
      "isSummary" : false,
      "mapping" : [{
        "identity" : "rim",
        "map" : "n/a"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.storage.extension",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.storage.extension",
      "slicing" : {
        "discriminator" : [{
          "type" : "value",
          "path" : "url"
        }],
        "description" : "Extensions are always sliced by (at least) url",
        "rules" : "open"
      },
      "short" : "Additional content defined by implementations",
      "definition" : "May be used to represent additional information that is not part of the basic definition of the element. To make the use of extensions safe and manageable, there is a strict set of governance  applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension.",
      "comment" : "There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions.  The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.",
      "alias" : ["extensions",
      "user content"],
      "min" : 0,
      "max" : "*",
      "base" : {
        "path" : "Element.extension",
        "min" : 0,
        "max" : "*"
      },
      "type" : [{
        "code" : "Extension"
      }],
      "constraint" : [{
        "key" : "ele-1",
        "severity" : "error",
        "human" : "All FHIR elements must have a @value or children",
        "expression" : "hasValue() or (children().count() > id.count())",
        "xpath" : "@value|f:*|h:div",
        "source" : "http://hl7.org/fhir/StructureDefinition/Element"
      },
      {
        "key" : "ext-1",
        "severity" : "error",
        "human" : "Must have either extensions or value[x], not both",
        "expression" : "extension.exists() != value.exists()",
        "xpath" : "exists(f:extension)!=exists(f:*[starts-with(local-name(.), \"value\")])",
        "source" : "http://hl7.org/fhir/StructureDefinition/Extension"
      }],
      "isModifier" : false,
      "isSummary" : false,
      "mapping" : [{
        "identity" : "rim",
        "map" : "n/a"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.storage.modifierExtension",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.storage.modifierExtension",
      "short" : "Extensions that cannot be ignored even if unrecognized",
      "definition" : "May be used to represent additional information that is not part of the basic definition of the element and that modifies the understanding of the element in which it is contained and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions.\n\nModifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself).",
      "comment" : "There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions.  The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.",
      "requirements" : "Modifier extensions allow for extensions that *cannot* be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored.  This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the [definition of modifier extensions](http://hl7.org/fhir/R4/extensibility.html#modifierExtension).",
      "alias" : ["extensions",
      "user content",
      "modifiers"],
      "min" : 0,
      "max" : "*",
      "base" : {
        "path" : "BackboneElement.modifierExtension",
        "min" : 0,
        "max" : "*"
      },
      "type" : [{
        "code" : "Extension"
      }],
      "constraint" : [{
        "key" : "ele-1",
        "severity" : "error",
        "human" : "All FHIR elements must have a @value or children",
        "expression" : "hasValue() or (children().count() > id.count())",
        "xpath" : "@value|f:*|h:div",
        "source" : "http://hl7.org/fhir/StructureDefinition/Element"
      },
      {
        "key" : "ext-1",
        "severity" : "error",
        "human" : "Must have either extensions or value[x], not both",
        "expression" : "extension.exists() != value.exists()",
        "xpath" : "exists(f:extension)!=exists(f:*[starts-with(local-name(.), \"value\")])",
        "source" : "http://hl7.org/fhir/StructureDefinition/Extension"
      }],
      "isModifier" : true,
      "isModifierReason" : "Modifier extensions are expected to modify the meaning or interpretation of the element that contains them",
      "isSummary" : true,
      "mapping" : [{
        "identity" : "rim",
        "map" : "N/A"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.storage.medicationStorageRemarks",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.storage.medicationStorageRemarks",
      "short" : "Are there any remarks or concerns regarding the (proper) home storage of medication? (SNOMED 422413002) | Answers: 710977001 Medication stored correctly | 424363005 Concern about proper home storage",
      "definition" : "Are there any remarks or concerns regarding the (proper) home storage of medication? (SNOMED 422413002) | Answers: 710977001 Medication stored correctly | 424363005 Concern about proper home storage",
      "min" : 1,
      "max" : "1",
      "base" : {
        "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.storage.medicationStorageRemarks",
        "min" : 1,
        "max" : "1"
      },
      "type" : [{
        "code" : "code"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.storage.storageRemarksSpecification",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.storage.storageRemarksSpecification",
      "short" : "Specify remarks or concerns (conditional: if medicationStorageRemarks = concern)",
      "definition" : "Specify remarks or concerns (conditional: if medicationStorageRemarks = concern)",
      "min" : 0,
      "max" : "1",
      "base" : {
        "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.storage.storageRemarksSpecification",
        "min" : 0,
        "max" : "1"
      },
      "type" : [{
        "code" : "string"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.observationParameters",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.observationParameters",
      "short" : "Observation Parameters",
      "definition" : "Observation Parameters",
      "min" : 1,
      "max" : "1",
      "base" : {
        "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.observationParameters",
        "min" : 1,
        "max" : "1"
      },
      "type" : [{
        "code" : "BackboneElement"
      }],
      "constraint" : [{
        "key" : "ele-1",
        "severity" : "error",
        "human" : "All FHIR elements must have a @value or children",
        "expression" : "hasValue() or (children().count() > id.count())",
        "xpath" : "@value|f:*|h:div",
        "source" : "http://hl7.org/fhir/StructureDefinition/Element"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.observationParameters.id",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.observationParameters.id",
      "representation" : ["xmlAttr"],
      "short" : "Unique id for inter-element referencing",
      "definition" : "Unique id for the element within a resource (for internal references). This may be any string value that does not contain spaces.",
      "min" : 0,
      "max" : "1",
      "base" : {
        "path" : "Element.id",
        "min" : 0,
        "max" : "1"
      },
      "type" : [{
        "extension" : [{
          "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-fhir-type",
          "valueUrl" : "string"
        }],
        "code" : "http://hl7.org/fhirpath/System.String"
      }],
      "isModifier" : false,
      "isSummary" : false,
      "mapping" : [{
        "identity" : "rim",
        "map" : "n/a"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.observationParameters.extension",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.observationParameters.extension",
      "slicing" : {
        "discriminator" : [{
          "type" : "value",
          "path" : "url"
        }],
        "description" : "Extensions are always sliced by (at least) url",
        "rules" : "open"
      },
      "short" : "Additional content defined by implementations",
      "definition" : "May be used to represent additional information that is not part of the basic definition of the element. To make the use of extensions safe and manageable, there is a strict set of governance  applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension.",
      "comment" : "There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions.  The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.",
      "alias" : ["extensions",
      "user content"],
      "min" : 0,
      "max" : "*",
      "base" : {
        "path" : "Element.extension",
        "min" : 0,
        "max" : "*"
      },
      "type" : [{
        "code" : "Extension"
      }],
      "constraint" : [{
        "key" : "ele-1",
        "severity" : "error",
        "human" : "All FHIR elements must have a @value or children",
        "expression" : "hasValue() or (children().count() > id.count())",
        "xpath" : "@value|f:*|h:div",
        "source" : "http://hl7.org/fhir/StructureDefinition/Element"
      },
      {
        "key" : "ext-1",
        "severity" : "error",
        "human" : "Must have either extensions or value[x], not both",
        "expression" : "extension.exists() != value.exists()",
        "xpath" : "exists(f:extension)!=exists(f:*[starts-with(local-name(.), \"value\")])",
        "source" : "http://hl7.org/fhir/StructureDefinition/Extension"
      }],
      "isModifier" : false,
      "isSummary" : false,
      "mapping" : [{
        "identity" : "rim",
        "map" : "n/a"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.observationParameters.modifierExtension",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.observationParameters.modifierExtension",
      "short" : "Extensions that cannot be ignored even if unrecognized",
      "definition" : "May be used to represent additional information that is not part of the basic definition of the element and that modifies the understanding of the element in which it is contained and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions.\n\nModifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself).",
      "comment" : "There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions.  The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.",
      "requirements" : "Modifier extensions allow for extensions that *cannot* be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored.  This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the [definition of modifier extensions](http://hl7.org/fhir/R4/extensibility.html#modifierExtension).",
      "alias" : ["extensions",
      "user content",
      "modifiers"],
      "min" : 0,
      "max" : "*",
      "base" : {
        "path" : "BackboneElement.modifierExtension",
        "min" : 0,
        "max" : "*"
      },
      "type" : [{
        "code" : "Extension"
      }],
      "constraint" : [{
        "key" : "ele-1",
        "severity" : "error",
        "human" : "All FHIR elements must have a @value or children",
        "expression" : "hasValue() or (children().count() > id.count())",
        "xpath" : "@value|f:*|h:div",
        "source" : "http://hl7.org/fhir/StructureDefinition/Element"
      },
      {
        "key" : "ext-1",
        "severity" : "error",
        "human" : "Must have either extensions or value[x], not both",
        "expression" : "extension.exists() != value.exists()",
        "xpath" : "exists(f:extension)!=exists(f:*[starts-with(local-name(.), \"value\")])",
        "source" : "http://hl7.org/fhir/StructureDefinition/Extension"
      }],
      "isModifier" : true,
      "isModifierReason" : "Modifier extensions are expected to modify the meaning or interpretation of the element that contains them",
      "isSummary" : true,
      "mapping" : [{
        "identity" : "rim",
        "map" : "N/A"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.observationParameters.bodyTemperature",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.observationParameters.bodyTemperature",
      "short" : "Body temperature (°C) (LOINC 8310-5)",
      "definition" : "Body temperature (°C) (LOINC 8310-5)",
      "min" : 1,
      "max" : "1",
      "base" : {
        "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.observationParameters.bodyTemperature",
        "min" : 1,
        "max" : "1"
      },
      "type" : [{
        "code" : "decimal"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.observationParameters.pulse",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.observationParameters.pulse",
      "short" : "Pulse (beats/min) (SNOMED 364075005)",
      "definition" : "Pulse (beats/min) (SNOMED 364075005)",
      "min" : 1,
      "max" : "1",
      "base" : {
        "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.observationParameters.pulse",
        "min" : 1,
        "max" : "1"
      },
      "type" : [{
        "code" : "decimal"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.observationParameters.bloodPressureSystolic",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.observationParameters.bloodPressureSystolic",
      "short" : "Blood pressure systolic (mmHg) (LOINC 8480-6)",
      "definition" : "Blood pressure systolic (mmHg) (LOINC 8480-6)",
      "min" : 1,
      "max" : "1",
      "base" : {
        "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.observationParameters.bloodPressureSystolic",
        "min" : 1,
        "max" : "1"
      },
      "type" : [{
        "code" : "decimal"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.observationParameters.bloodPressureDiastolic",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.observationParameters.bloodPressureDiastolic",
      "short" : "Blood pressure diastolic (mmHg) (LOINC 8462-4)",
      "definition" : "Blood pressure diastolic (mmHg) (LOINC 8462-4)",
      "min" : 1,
      "max" : "1",
      "base" : {
        "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.observationParameters.bloodPressureDiastolic",
        "min" : 1,
        "max" : "1"
      },
      "type" : [{
        "code" : "decimal"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.observationParameters.oxygenSaturation",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.observationParameters.oxygenSaturation",
      "short" : "Oxygen saturation (%) (LOINC 2708-6) — Only measure if cough or shortness of breath is present",
      "definition" : "Oxygen saturation (%) (LOINC 2708-6) — Only measure if cough or shortness of breath is present",
      "min" : 0,
      "max" : "1",
      "base" : {
        "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.observationParameters.oxygenSaturation",
        "min" : 0,
        "max" : "1"
      },
      "type" : [{
        "code" : "decimal"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications",
      "short" : "Contraindications",
      "definition" : "Contraindications",
      "min" : 1,
      "max" : "1",
      "base" : {
        "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications",
        "min" : 1,
        "max" : "1"
      },
      "type" : [{
        "code" : "BackboneElement"
      }],
      "constraint" : [{
        "key" : "ele-1",
        "severity" : "error",
        "human" : "All FHIR elements must have a @value or children",
        "expression" : "hasValue() or (children().count() > id.count())",
        "xpath" : "@value|f:*|h:div",
        "source" : "http://hl7.org/fhir/StructureDefinition/Element"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.id",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.id",
      "representation" : ["xmlAttr"],
      "short" : "Unique id for inter-element referencing",
      "definition" : "Unique id for the element within a resource (for internal references). This may be any string value that does not contain spaces.",
      "min" : 0,
      "max" : "1",
      "base" : {
        "path" : "Element.id",
        "min" : 0,
        "max" : "1"
      },
      "type" : [{
        "extension" : [{
          "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-fhir-type",
          "valueUrl" : "string"
        }],
        "code" : "http://hl7.org/fhirpath/System.String"
      }],
      "isModifier" : false,
      "isSummary" : false,
      "mapping" : [{
        "identity" : "rim",
        "map" : "n/a"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.extension",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.extension",
      "slicing" : {
        "discriminator" : [{
          "type" : "value",
          "path" : "url"
        }],
        "description" : "Extensions are always sliced by (at least) url",
        "rules" : "open"
      },
      "short" : "Additional content defined by implementations",
      "definition" : "May be used to represent additional information that is not part of the basic definition of the element. To make the use of extensions safe and manageable, there is a strict set of governance  applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension.",
      "comment" : "There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions.  The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.",
      "alias" : ["extensions",
      "user content"],
      "min" : 0,
      "max" : "*",
      "base" : {
        "path" : "Element.extension",
        "min" : 0,
        "max" : "*"
      },
      "type" : [{
        "code" : "Extension"
      }],
      "constraint" : [{
        "key" : "ele-1",
        "severity" : "error",
        "human" : "All FHIR elements must have a @value or children",
        "expression" : "hasValue() or (children().count() > id.count())",
        "xpath" : "@value|f:*|h:div",
        "source" : "http://hl7.org/fhir/StructureDefinition/Element"
      },
      {
        "key" : "ext-1",
        "severity" : "error",
        "human" : "Must have either extensions or value[x], not both",
        "expression" : "extension.exists() != value.exists()",
        "xpath" : "exists(f:extension)!=exists(f:*[starts-with(local-name(.), \"value\")])",
        "source" : "http://hl7.org/fhir/StructureDefinition/Extension"
      }],
      "isModifier" : false,
      "isSummary" : false,
      "mapping" : [{
        "identity" : "rim",
        "map" : "n/a"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.modifierExtension",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.modifierExtension",
      "short" : "Extensions that cannot be ignored even if unrecognized",
      "definition" : "May be used to represent additional information that is not part of the basic definition of the element and that modifies the understanding of the element in which it is contained and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions.\n\nModifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself).",
      "comment" : "There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions.  The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.",
      "requirements" : "Modifier extensions allow for extensions that *cannot* be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored.  This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the [definition of modifier extensions](http://hl7.org/fhir/R4/extensibility.html#modifierExtension).",
      "alias" : ["extensions",
      "user content",
      "modifiers"],
      "min" : 0,
      "max" : "*",
      "base" : {
        "path" : "BackboneElement.modifierExtension",
        "min" : 0,
        "max" : "*"
      },
      "type" : [{
        "code" : "Extension"
      }],
      "constraint" : [{
        "key" : "ele-1",
        "severity" : "error",
        "human" : "All FHIR elements must have a @value or children",
        "expression" : "hasValue() or (children().count() > id.count())",
        "xpath" : "@value|f:*|h:div",
        "source" : "http://hl7.org/fhir/StructureDefinition/Element"
      },
      {
        "key" : "ext-1",
        "severity" : "error",
        "human" : "Must have either extensions or value[x], not both",
        "expression" : "extension.exists() != value.exists()",
        "xpath" : "exists(f:extension)!=exists(f:*[starts-with(local-name(.), \"value\")])",
        "source" : "http://hl7.org/fhir/StructureDefinition/Extension"
      }],
      "isModifier" : true,
      "isModifierReason" : "Modifier extensions are expected to modify the meaning or interpretation of the element that contains them",
      "isSummary" : true,
      "mapping" : [{
        "identity" : "rim",
        "map" : "N/A"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.anyContraindication",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.anyContraindication",
      "short" : "Are there contraindications for administration? (SNOMED 395008009) | Answers: 373066001 Yes | 373067005 No",
      "definition" : "Are there contraindications for administration? (SNOMED 395008009) | Answers: 373066001 Yes | 373067005 No",
      "min" : 1,
      "max" : "1",
      "base" : {
        "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.anyContraindication",
        "min" : 1,
        "max" : "1"
      },
      "type" : [{
        "code" : "code"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.feverChillsUnwell",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.feverChillsUnwell",
      "short" : "Fever, chills, feeling unwell (SNOMED 39104002) | Answers: 373066001 Yes | 373067005 No (conditional: if anyContraindication = Yes)",
      "definition" : "Fever, chills, feeling unwell (SNOMED 39104002) | Answers: 373066001 Yes | 373067005 No (conditional: if anyContraindication = Yes)",
      "min" : 0,
      "max" : "1",
      "base" : {
        "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.feverChillsUnwell",
        "min" : 0,
        "max" : "1"
      },
      "type" : [{
        "code" : "code"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.noOralIntake",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.noOralIntake",
      "short" : "No oral intake due to reduced appetite or taste changes (SNOMED 247318005) | Answers: 373066001 Yes | 373067005 No",
      "definition" : "No oral intake due to reduced appetite or taste changes (SNOMED 247318005) | Answers: 373066001 Yes | 373067005 No",
      "min" : 0,
      "max" : "1",
      "base" : {
        "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.noOralIntake",
        "min" : 0,
        "max" : "1"
      },
      "type" : [{
        "code" : "code"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.severeNausea",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.severeNausea",
      "short" : "Severe nausea (nausea with insufficient oral intake) (SNOMED 73335002) | Answers: 373066001 Yes | 373067005 No",
      "definition" : "Severe nausea (nausea with insufficient oral intake) (SNOMED 73335002) | Answers: 373066001 Yes | 373067005 No",
      "min" : 0,
      "max" : "1",
      "base" : {
        "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.severeNausea",
        "min" : 0,
        "max" : "1"
      },
      "type" : [{
        "code" : "code"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.increasedDyspnea",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.increasedDyspnea",
      "short" : "Increased or severe shortness of breath (at rest or impacting daily activities) (SNOMED 297216006) | Answers: 373066001 Yes | 373067005 No",
      "definition" : "Increased or severe shortness of breath (at rest or impacting daily activities) (SNOMED 297216006) | Answers: 373066001 Yes | 373067005 No",
      "min" : 0,
      "max" : "1",
      "base" : {
        "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.increasedDyspnea",
        "min" : 0,
        "max" : "1"
      },
      "type" : [{
        "code" : "code"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.newOrIncreasedCough",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.newOrIncreasedCough",
      "short" : "New or increased productive/dry cough, with or without dyspnea (SNOMED 11833005) | Answers: 373066001 Yes | 373067005 No",
      "definition" : "New or increased productive/dry cough, with or without dyspnea (SNOMED 11833005) | Answers: 373066001 Yes | 373067005 No",
      "min" : 0,
      "max" : "1",
      "base" : {
        "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.newOrIncreasedCough",
        "min" : 0,
        "max" : "1"
      },
      "type" : [{
        "code" : "code"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.generalDeterioration",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.generalDeterioration",
      "short" : "General deterioration (SNOMED 154091000119106) | Answers: 373066001 Yes | 373067005 No",
      "definition" : "General deterioration (SNOMED 154091000119106) | Answers: 373066001 Yes | 373067005 No",
      "min" : 0,
      "max" : "1",
      "base" : {
        "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.generalDeterioration",
        "min" : 0,
        "max" : "1"
      },
      "type" : [{
        "code" : "code"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.decisionAfterConsultation",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.decisionAfterConsultation",
      "short" : "Decision after consultation with hospital (SNOMED 182836005) | Answers: Administration | No administration | Other",
      "definition" : "Decision after consultation with hospital (SNOMED 182836005) | Answers: Administration | No administration | Other",
      "min" : 0,
      "max" : "1",
      "base" : {
        "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.decisionAfterConsultation",
        "min" : 0,
        "max" : "1"
      },
      "type" : [{
        "code" : "code"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.decisionOtherSpecification",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.decisionOtherSpecification",
      "short" : "Specify if decision = Other (SNOMED 438833006)",
      "definition" : "Specify if decision = Other (SNOMED 438833006)",
      "min" : 0,
      "max" : "1",
      "base" : {
        "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.decisionOtherSpecification",
        "min" : 0,
        "max" : "1"
      },
      "type" : [{
        "code" : "string"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden",
      "short" : "Symptom Burden",
      "definition" : "Symptom Burden",
      "min" : 1,
      "max" : "1",
      "base" : {
        "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden",
        "min" : 1,
        "max" : "1"
      },
      "type" : [{
        "code" : "BackboneElement"
      }],
      "constraint" : [{
        "key" : "ele-1",
        "severity" : "error",
        "human" : "All FHIR elements must have a @value or children",
        "expression" : "hasValue() or (children().count() > id.count())",
        "xpath" : "@value|f:*|h:div",
        "source" : "http://hl7.org/fhir/StructureDefinition/Element"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.id",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.id",
      "representation" : ["xmlAttr"],
      "short" : "Unique id for inter-element referencing",
      "definition" : "Unique id for the element within a resource (for internal references). This may be any string value that does not contain spaces.",
      "min" : 0,
      "max" : "1",
      "base" : {
        "path" : "Element.id",
        "min" : 0,
        "max" : "1"
      },
      "type" : [{
        "extension" : [{
          "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-fhir-type",
          "valueUrl" : "string"
        }],
        "code" : "http://hl7.org/fhirpath/System.String"
      }],
      "isModifier" : false,
      "isSummary" : false,
      "mapping" : [{
        "identity" : "rim",
        "map" : "n/a"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.extension",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.extension",
      "slicing" : {
        "discriminator" : [{
          "type" : "value",
          "path" : "url"
        }],
        "description" : "Extensions are always sliced by (at least) url",
        "rules" : "open"
      },
      "short" : "Additional content defined by implementations",
      "definition" : "May be used to represent additional information that is not part of the basic definition of the element. To make the use of extensions safe and manageable, there is a strict set of governance  applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension.",
      "comment" : "There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions.  The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.",
      "alias" : ["extensions",
      "user content"],
      "min" : 0,
      "max" : "*",
      "base" : {
        "path" : "Element.extension",
        "min" : 0,
        "max" : "*"
      },
      "type" : [{
        "code" : "Extension"
      }],
      "constraint" : [{
        "key" : "ele-1",
        "severity" : "error",
        "human" : "All FHIR elements must have a @value or children",
        "expression" : "hasValue() or (children().count() > id.count())",
        "xpath" : "@value|f:*|h:div",
        "source" : "http://hl7.org/fhir/StructureDefinition/Element"
      },
      {
        "key" : "ext-1",
        "severity" : "error",
        "human" : "Must have either extensions or value[x], not both",
        "expression" : "extension.exists() != value.exists()",
        "xpath" : "exists(f:extension)!=exists(f:*[starts-with(local-name(.), \"value\")])",
        "source" : "http://hl7.org/fhir/StructureDefinition/Extension"
      }],
      "isModifier" : false,
      "isSummary" : false,
      "mapping" : [{
        "identity" : "rim",
        "map" : "n/a"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.modifierExtension",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.modifierExtension",
      "short" : "Extensions that cannot be ignored even if unrecognized",
      "definition" : "May be used to represent additional information that is not part of the basic definition of the element and that modifies the understanding of the element in which it is contained and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions.\n\nModifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself).",
      "comment" : "There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions.  The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.",
      "requirements" : "Modifier extensions allow for extensions that *cannot* be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored.  This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the [definition of modifier extensions](http://hl7.org/fhir/R4/extensibility.html#modifierExtension).",
      "alias" : ["extensions",
      "user content",
      "modifiers"],
      "min" : 0,
      "max" : "*",
      "base" : {
        "path" : "BackboneElement.modifierExtension",
        "min" : 0,
        "max" : "*"
      },
      "type" : [{
        "code" : "Extension"
      }],
      "constraint" : [{
        "key" : "ele-1",
        "severity" : "error",
        "human" : "All FHIR elements must have a @value or children",
        "expression" : "hasValue() or (children().count() > id.count())",
        "xpath" : "@value|f:*|h:div",
        "source" : "http://hl7.org/fhir/StructureDefinition/Element"
      },
      {
        "key" : "ext-1",
        "severity" : "error",
        "human" : "Must have either extensions or value[x], not both",
        "expression" : "extension.exists() != value.exists()",
        "xpath" : "exists(f:extension)!=exists(f:*[starts-with(local-name(.), \"value\")])",
        "source" : "http://hl7.org/fhir/StructureDefinition/Extension"
      }],
      "isModifier" : true,
      "isModifierReason" : "Modifier extensions are expected to modify the meaning or interpretation of the element that contains them",
      "isSummary" : true,
      "mapping" : [{
        "identity" : "rim",
        "map" : "N/A"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.nausea",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.nausea",
      "short" : "Nausea (SNOMED 422587007) | Answers: 444431007 Grade 0 (None) | 444456001 Grade 1 | 444457005 Grade 2 | 444447009 Grade 3",
      "definition" : "Nausea (SNOMED 422587007) | Answers: 444431007 Grade 0 (None) | 444456001 Grade 1 | 444457005 Grade 2 | 444447009 Grade 3",
      "min" : 1,
      "max" : "1",
      "base" : {
        "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.nausea",
        "min" : 1,
        "max" : "1"
      },
      "type" : [{
        "code" : "code"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.vomiting",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.vomiting",
      "short" : "Vomiting (SNOMED 249497008) | Answers: 444431007 Grade 0 | 444456001 Grade 1 (<=2 times) | 444457005 Grade 2 (3-5 times) | 444447009 Grade 3 (6+ times)",
      "definition" : "Vomiting (SNOMED 249497008) | Answers: 444431007 Grade 0 | 444456001 Grade 1 (<=2 times) | 444457005 Grade 2 (3-5 times) | 444447009 Grade 3 (6+ times)",
      "min" : 1,
      "max" : "1",
      "base" : {
        "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.vomiting",
        "min" : 1,
        "max" : "1"
      },
      "type" : [{
        "code" : "code"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.reducedAppetiteOrTasteChanges",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.reducedAppetiteOrTasteChanges",
      "short" : "Reduced appetite or taste changes (SNOMED 64379006) | Answers: 444431007 Grade 0 | 444456001 Grade 1 | 444457005 Grade 2 | 444447009 Grade 3",
      "definition" : "Reduced appetite or taste changes (SNOMED 64379006) | Answers: 444431007 Grade 0 | 444456001 Grade 1 | 444457005 Grade 2 | 444447009 Grade 3",
      "min" : 1,
      "max" : "1",
      "base" : {
        "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.reducedAppetiteOrTasteChanges",
        "min" : 1,
        "max" : "1"
      },
      "type" : [{
        "code" : "code"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.diarrhea",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.diarrhea",
      "short" : "Diarrhea (SNOMED 62315008) | Answers: 444431007 Grade 0 | 444456001 Grade 1 (1-3x more) | 444457005 Grade 2 (4-6x more) | 444447009 Grade 3 (>6x or impacting daily life)",
      "definition" : "Diarrhea (SNOMED 62315008) | Answers: 444431007 Grade 0 | 444456001 Grade 1 (1-3x more) | 444457005 Grade 2 (4-6x more) | 444447009 Grade 3 (>6x or impacting daily life)",
      "min" : 1,
      "max" : "1",
      "base" : {
        "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.diarrhea",
        "min" : 1,
        "max" : "1"
      },
      "type" : [{
        "code" : "code"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.constipation",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.constipation",
      "short" : "Constipation (SNOMED 14760008) | Answers: 444431007 Grade 0 | 444456001 Grade 1 | 444457005 Grade 2 | 444447009 Grade 3",
      "definition" : "Constipation (SNOMED 14760008) | Answers: 444431007 Grade 0 | 444456001 Grade 1 | 444457005 Grade 2 | 444447009 Grade 3",
      "min" : 1,
      "max" : "1",
      "base" : {
        "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.constipation",
        "min" : 1,
        "max" : "1"
      },
      "type" : [{
        "code" : "code"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.fatigue",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.fatigue",
      "short" : "Fatigue / lack of energy (SNOMED 224960004) | Answers: 444431007 Grade 0 | 444456001 Grade 1 (mild) | 444457005 Grade 2 (moderate) | 444447009 Grade 3 (severe)",
      "definition" : "Fatigue / lack of energy (SNOMED 224960004) | Answers: 444431007 Grade 0 | 444456001 Grade 1 (mild) | 444457005 Grade 2 (moderate) | 444447009 Grade 3 (severe)",
      "min" : 1,
      "max" : "1",
      "base" : {
        "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.fatigue",
        "min" : 1,
        "max" : "1"
      },
      "type" : [{
        "code" : "code"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.pain",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.pain",
      "short" : "Pain (SNOMED 112104007) | Answers: 444431007 Grade 0 | 444456001 Grade 1 (mild) | 444457005 Grade 2 (moderate) | 444447009 Grade 3 (severe)",
      "definition" : "Pain (SNOMED 112104007) | Answers: 444431007 Grade 0 | 444456001 Grade 1 (mild) | 444457005 Grade 2 (moderate) | 444447009 Grade 3 (severe)",
      "min" : 1,
      "max" : "1",
      "base" : {
        "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.pain",
        "min" : 1,
        "max" : "1"
      },
      "type" : [{
        "code" : "code"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.skinRash",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.skinRash",
      "short" : "Skin rash (SNOMED 271807003) | Answers: 444431007 Grade 0 | 444456001 Grade 1 (limited redness) | 444457005 Grade 2 (moderate redness) | 444447009 Grade 3 (severe/extensive redness or peeling)",
      "definition" : "Skin rash (SNOMED 271807003) | Answers: 444431007 Grade 0 | 444456001 Grade 1 (limited redness) | 444457005 Grade 2 (moderate redness) | 444447009 Grade 3 (severe/extensive redness or peeling)",
      "min" : 1,
      "max" : "1",
      "base" : {
        "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.skinRash",
        "min" : 1,
        "max" : "1"
      },
      "type" : [{
        "code" : "code"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.psychosocialBurden",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.psychosocialBurden",
      "short" : "Psychosocial burden (SNOMED 384821006) | Answers: 444431007 Grade 0 (Feels well) | 444456001 Grade 1 (mild distress) | 444457005 Grade 2 (moderate impact) | 444447009 Grade 3 (severe impact)",
      "definition" : "Psychosocial burden (SNOMED 384821006) | Answers: 444431007 Grade 0 (Feels well) | 444456001 Grade 1 (mild distress) | 444457005 Grade 2 (moderate impact) | 444447009 Grade 3 (severe impact)",
      "min" : 1,
      "max" : "1",
      "base" : {
        "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.psychosocialBurden",
        "min" : 1,
        "max" : "1"
      },
      "type" : [{
        "code" : "code"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.shortnessOfBreath",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.shortnessOfBreath",
      "short" : "Shortness of breath (SNOMED 267036007) | Answers: 444431007 Grade 0 | 444456001 Grade 1 (moderate exertion only) | 444457005 Grade 2 (light exertion affecting daily activities) | 444447009 Grade 3 (at rest affecting daily activities)",
      "definition" : "Shortness of breath (SNOMED 267036007) | Answers: 444431007 Grade 0 | 444456001 Grade 1 (moderate exertion only) | 444457005 Grade 2 (light exertion affecting daily activities) | 444447009 Grade 3 (at rest affecting daily activities)",
      "min" : 1,
      "max" : "1",
      "base" : {
        "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.shortnessOfBreath",
        "min" : 1,
        "max" : "1"
      },
      "type" : [{
        "code" : "code"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.cough",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.cough",
      "short" : "Cough (SNOMED 49727002) | Answers: 444431007 Grade 0 | 444456001 Grade 1 (mild) | 444457005 Grade 2 (moderate) | 444447009 Grade 3 (severe)",
      "definition" : "Cough (SNOMED 49727002) | Answers: 444431007 Grade 0 | 444456001 Grade 1 (mild) | 444457005 Grade 2 (moderate) | 444447009 Grade 3 (severe)",
      "min" : 1,
      "max" : "1",
      "base" : {
        "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.cough",
        "min" : 1,
        "max" : "1"
      },
      "type" : [{
        "code" : "code"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.otherRelevantObservations",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.otherRelevantObservations",
      "short" : "Other Relevant Observations",
      "definition" : "Other Relevant Observations",
      "min" : 0,
      "max" : "1",
      "base" : {
        "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.otherRelevantObservations",
        "min" : 0,
        "max" : "1"
      },
      "type" : [{
        "code" : "BackboneElement"
      }],
      "constraint" : [{
        "key" : "ele-1",
        "severity" : "error",
        "human" : "All FHIR elements must have a @value or children",
        "expression" : "hasValue() or (children().count() > id.count())",
        "xpath" : "@value|f:*|h:div",
        "source" : "http://hl7.org/fhir/StructureDefinition/Element"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.otherRelevantObservations.id",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.otherRelevantObservations.id",
      "representation" : ["xmlAttr"],
      "short" : "Unique id for inter-element referencing",
      "definition" : "Unique id for the element within a resource (for internal references). This may be any string value that does not contain spaces.",
      "min" : 0,
      "max" : "1",
      "base" : {
        "path" : "Element.id",
        "min" : 0,
        "max" : "1"
      },
      "type" : [{
        "extension" : [{
          "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-fhir-type",
          "valueUrl" : "string"
        }],
        "code" : "http://hl7.org/fhirpath/System.String"
      }],
      "isModifier" : false,
      "isSummary" : false,
      "mapping" : [{
        "identity" : "rim",
        "map" : "n/a"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.otherRelevantObservations.extension",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.otherRelevantObservations.extension",
      "slicing" : {
        "discriminator" : [{
          "type" : "value",
          "path" : "url"
        }],
        "description" : "Extensions are always sliced by (at least) url",
        "rules" : "open"
      },
      "short" : "Additional content defined by implementations",
      "definition" : "May be used to represent additional information that is not part of the basic definition of the element. To make the use of extensions safe and manageable, there is a strict set of governance  applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension.",
      "comment" : "There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions.  The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.",
      "alias" : ["extensions",
      "user content"],
      "min" : 0,
      "max" : "*",
      "base" : {
        "path" : "Element.extension",
        "min" : 0,
        "max" : "*"
      },
      "type" : [{
        "code" : "Extension"
      }],
      "constraint" : [{
        "key" : "ele-1",
        "severity" : "error",
        "human" : "All FHIR elements must have a @value or children",
        "expression" : "hasValue() or (children().count() > id.count())",
        "xpath" : "@value|f:*|h:div",
        "source" : "http://hl7.org/fhir/StructureDefinition/Element"
      },
      {
        "key" : "ext-1",
        "severity" : "error",
        "human" : "Must have either extensions or value[x], not both",
        "expression" : "extension.exists() != value.exists()",
        "xpath" : "exists(f:extension)!=exists(f:*[starts-with(local-name(.), \"value\")])",
        "source" : "http://hl7.org/fhir/StructureDefinition/Extension"
      }],
      "isModifier" : false,
      "isSummary" : false,
      "mapping" : [{
        "identity" : "rim",
        "map" : "n/a"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.otherRelevantObservations.modifierExtension",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.otherRelevantObservations.modifierExtension",
      "short" : "Extensions that cannot be ignored even if unrecognized",
      "definition" : "May be used to represent additional information that is not part of the basic definition of the element and that modifies the understanding of the element in which it is contained and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions.\n\nModifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself).",
      "comment" : "There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions.  The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.",
      "requirements" : "Modifier extensions allow for extensions that *cannot* be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored.  This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the [definition of modifier extensions](http://hl7.org/fhir/R4/extensibility.html#modifierExtension).",
      "alias" : ["extensions",
      "user content",
      "modifiers"],
      "min" : 0,
      "max" : "*",
      "base" : {
        "path" : "BackboneElement.modifierExtension",
        "min" : 0,
        "max" : "*"
      },
      "type" : [{
        "code" : "Extension"
      }],
      "constraint" : [{
        "key" : "ele-1",
        "severity" : "error",
        "human" : "All FHIR elements must have a @value or children",
        "expression" : "hasValue() or (children().count() > id.count())",
        "xpath" : "@value|f:*|h:div",
        "source" : "http://hl7.org/fhir/StructureDefinition/Element"
      },
      {
        "key" : "ext-1",
        "severity" : "error",
        "human" : "Must have either extensions or value[x], not both",
        "expression" : "extension.exists() != value.exists()",
        "xpath" : "exists(f:extension)!=exists(f:*[starts-with(local-name(.), \"value\")])",
        "source" : "http://hl7.org/fhir/StructureDefinition/Extension"
      }],
      "isModifier" : true,
      "isModifierReason" : "Modifier extensions are expected to modify the meaning or interpretation of the element that contains them",
      "isSummary" : true,
      "mapping" : [{
        "identity" : "rim",
        "map" : "N/A"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.otherRelevantObservations.otherObservations",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.otherRelevantObservations.otherObservations",
      "short" : "Other side effects or relevant clinical and psychosocial observations. Contact hospital in case of clinical concern. (SNOMED 365275006)",
      "definition" : "Other side effects or relevant clinical and psychosocial observations. Contact hospital in case of clinical concern. (SNOMED 365275006)",
      "min" : 0,
      "max" : "1",
      "base" : {
        "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.otherRelevantObservations.otherObservations",
        "min" : 0,
        "max" : "1"
      },
      "type" : [{
        "code" : "string"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.task",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.task",
      "short" : "Task",
      "definition" : "Task",
      "min" : 1,
      "max" : "1",
      "base" : {
        "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.task",
        "min" : 1,
        "max" : "1"
      },
      "type" : [{
        "code" : "BackboneElement"
      }],
      "constraint" : [{
        "key" : "ele-1",
        "severity" : "error",
        "human" : "All FHIR elements must have a @value or children",
        "expression" : "hasValue() or (children().count() > id.count())",
        "xpath" : "@value|f:*|h:div",
        "source" : "http://hl7.org/fhir/StructureDefinition/Element"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.task.id",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.task.id",
      "representation" : ["xmlAttr"],
      "short" : "Unique id for inter-element referencing",
      "definition" : "Unique id for the element within a resource (for internal references). This may be any string value that does not contain spaces.",
      "min" : 0,
      "max" : "1",
      "base" : {
        "path" : "Element.id",
        "min" : 0,
        "max" : "1"
      },
      "type" : [{
        "extension" : [{
          "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-fhir-type",
          "valueUrl" : "string"
        }],
        "code" : "http://hl7.org/fhirpath/System.String"
      }],
      "isModifier" : false,
      "isSummary" : false,
      "mapping" : [{
        "identity" : "rim",
        "map" : "n/a"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.task.extension",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.task.extension",
      "slicing" : {
        "discriminator" : [{
          "type" : "value",
          "path" : "url"
        }],
        "description" : "Extensions are always sliced by (at least) url",
        "rules" : "open"
      },
      "short" : "Additional content defined by implementations",
      "definition" : "May be used to represent additional information that is not part of the basic definition of the element. To make the use of extensions safe and manageable, there is a strict set of governance  applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension.",
      "comment" : "There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions.  The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.",
      "alias" : ["extensions",
      "user content"],
      "min" : 0,
      "max" : "*",
      "base" : {
        "path" : "Element.extension",
        "min" : 0,
        "max" : "*"
      },
      "type" : [{
        "code" : "Extension"
      }],
      "constraint" : [{
        "key" : "ele-1",
        "severity" : "error",
        "human" : "All FHIR elements must have a @value or children",
        "expression" : "hasValue() or (children().count() > id.count())",
        "xpath" : "@value|f:*|h:div",
        "source" : "http://hl7.org/fhir/StructureDefinition/Element"
      },
      {
        "key" : "ext-1",
        "severity" : "error",
        "human" : "Must have either extensions or value[x], not both",
        "expression" : "extension.exists() != value.exists()",
        "xpath" : "exists(f:extension)!=exists(f:*[starts-with(local-name(.), \"value\")])",
        "source" : "http://hl7.org/fhir/StructureDefinition/Extension"
      }],
      "isModifier" : false,
      "isSummary" : false,
      "mapping" : [{
        "identity" : "rim",
        "map" : "n/a"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.task.modifierExtension",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.task.modifierExtension",
      "short" : "Extensions that cannot be ignored even if unrecognized",
      "definition" : "May be used to represent additional information that is not part of the basic definition of the element and that modifies the understanding of the element in which it is contained and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions.\n\nModifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself).",
      "comment" : "There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions.  The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.",
      "requirements" : "Modifier extensions allow for extensions that *cannot* be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored.  This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the [definition of modifier extensions](http://hl7.org/fhir/R4/extensibility.html#modifierExtension).",
      "alias" : ["extensions",
      "user content",
      "modifiers"],
      "min" : 0,
      "max" : "*",
      "base" : {
        "path" : "BackboneElement.modifierExtension",
        "min" : 0,
        "max" : "*"
      },
      "type" : [{
        "code" : "Extension"
      }],
      "constraint" : [{
        "key" : "ele-1",
        "severity" : "error",
        "human" : "All FHIR elements must have a @value or children",
        "expression" : "hasValue() or (children().count() > id.count())",
        "xpath" : "@value|f:*|h:div",
        "source" : "http://hl7.org/fhir/StructureDefinition/Element"
      },
      {
        "key" : "ext-1",
        "severity" : "error",
        "human" : "Must have either extensions or value[x], not both",
        "expression" : "extension.exists() != value.exists()",
        "xpath" : "exists(f:extension)!=exists(f:*[starts-with(local-name(.), \"value\")])",
        "source" : "http://hl7.org/fhir/StructureDefinition/Extension"
      }],
      "isModifier" : true,
      "isModifierReason" : "Modifier extensions are expected to modify the meaning or interpretation of the element that contains them",
      "isSummary" : true,
      "mapping" : [{
        "identity" : "rim",
        "map" : "N/A"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.task.medicationDissolvedClear",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.task.medicationDissolvedClear",
      "short" : "Medication was completely dissolved into a clear solution without visible particles (SNOMED 396076000) | Answers: 373066001 Yes | 373067005 No",
      "definition" : "Medication was completely dissolved into a clear solution without visible particles (SNOMED 396076000) | Answers: 373066001 Yes | 373067005 No",
      "min" : 1,
      "max" : "1",
      "base" : {
        "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.task.medicationDissolvedClear",
        "min" : 1,
        "max" : "1"
      },
      "type" : [{
        "code" : "code"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.task.medicationAdministeredPerProcedure",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.task.medicationAdministeredPerProcedure",
      "short" : "Could the medication be administered exactly according to the procedure (no deviations)? (SNOMED 373149000) | Answers: 373066001 Yes | 373067005 No",
      "definition" : "Could the medication be administered exactly according to the procedure (no deviations)? (SNOMED 373149000) | Answers: 373066001 Yes | 373067005 No",
      "min" : 1,
      "max" : "1",
      "base" : {
        "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.task.medicationAdministeredPerProcedure",
        "min" : 1,
        "max" : "1"
      },
      "type" : [{
        "code" : "code"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.qualityFollowUp",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.qualityFollowUp",
      "short" : "Quality Follow-Up",
      "definition" : "Quality Follow-Up",
      "min" : 0,
      "max" : "1",
      "base" : {
        "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.qualityFollowUp",
        "min" : 0,
        "max" : "1"
      },
      "type" : [{
        "code" : "BackboneElement"
      }],
      "constraint" : [{
        "key" : "ele-1",
        "severity" : "error",
        "human" : "All FHIR elements must have a @value or children",
        "expression" : "hasValue() or (children().count() > id.count())",
        "xpath" : "@value|f:*|h:div",
        "source" : "http://hl7.org/fhir/StructureDefinition/Element"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.qualityFollowUp.id",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.qualityFollowUp.id",
      "representation" : ["xmlAttr"],
      "short" : "Unique id for inter-element referencing",
      "definition" : "Unique id for the element within a resource (for internal references). This may be any string value that does not contain spaces.",
      "min" : 0,
      "max" : "1",
      "base" : {
        "path" : "Element.id",
        "min" : 0,
        "max" : "1"
      },
      "type" : [{
        "extension" : [{
          "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-fhir-type",
          "valueUrl" : "string"
        }],
        "code" : "http://hl7.org/fhirpath/System.String"
      }],
      "isModifier" : false,
      "isSummary" : false,
      "mapping" : [{
        "identity" : "rim",
        "map" : "n/a"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.qualityFollowUp.extension",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.qualityFollowUp.extension",
      "slicing" : {
        "discriminator" : [{
          "type" : "value",
          "path" : "url"
        }],
        "description" : "Extensions are always sliced by (at least) url",
        "rules" : "open"
      },
      "short" : "Additional content defined by implementations",
      "definition" : "May be used to represent additional information that is not part of the basic definition of the element. To make the use of extensions safe and manageable, there is a strict set of governance  applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension.",
      "comment" : "There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions.  The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.",
      "alias" : ["extensions",
      "user content"],
      "min" : 0,
      "max" : "*",
      "base" : {
        "path" : "Element.extension",
        "min" : 0,
        "max" : "*"
      },
      "type" : [{
        "code" : "Extension"
      }],
      "constraint" : [{
        "key" : "ele-1",
        "severity" : "error",
        "human" : "All FHIR elements must have a @value or children",
        "expression" : "hasValue() or (children().count() > id.count())",
        "xpath" : "@value|f:*|h:div",
        "source" : "http://hl7.org/fhir/StructureDefinition/Element"
      },
      {
        "key" : "ext-1",
        "severity" : "error",
        "human" : "Must have either extensions or value[x], not both",
        "expression" : "extension.exists() != value.exists()",
        "xpath" : "exists(f:extension)!=exists(f:*[starts-with(local-name(.), \"value\")])",
        "source" : "http://hl7.org/fhir/StructureDefinition/Extension"
      }],
      "isModifier" : false,
      "isSummary" : false,
      "mapping" : [{
        "identity" : "rim",
        "map" : "n/a"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.qualityFollowUp.modifierExtension",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.qualityFollowUp.modifierExtension",
      "short" : "Extensions that cannot be ignored even if unrecognized",
      "definition" : "May be used to represent additional information that is not part of the basic definition of the element and that modifies the understanding of the element in which it is contained and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions.\n\nModifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself).",
      "comment" : "There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions.  The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.",
      "requirements" : "Modifier extensions allow for extensions that *cannot* be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored.  This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the [definition of modifier extensions](http://hl7.org/fhir/R4/extensibility.html#modifierExtension).",
      "alias" : ["extensions",
      "user content",
      "modifiers"],
      "min" : 0,
      "max" : "*",
      "base" : {
        "path" : "BackboneElement.modifierExtension",
        "min" : 0,
        "max" : "*"
      },
      "type" : [{
        "code" : "Extension"
      }],
      "constraint" : [{
        "key" : "ele-1",
        "severity" : "error",
        "human" : "All FHIR elements must have a @value or children",
        "expression" : "hasValue() or (children().count() > id.count())",
        "xpath" : "@value|f:*|h:div",
        "source" : "http://hl7.org/fhir/StructureDefinition/Element"
      },
      {
        "key" : "ext-1",
        "severity" : "error",
        "human" : "Must have either extensions or value[x], not both",
        "expression" : "extension.exists() != value.exists()",
        "xpath" : "exists(f:extension)!=exists(f:*[starts-with(local-name(.), \"value\")])",
        "source" : "http://hl7.org/fhir/StructureDefinition/Extension"
      }],
      "isModifier" : true,
      "isModifierReason" : "Modifier extensions are expected to modify the meaning or interpretation of the element that contains them",
      "isSummary" : true,
      "mapping" : [{
        "identity" : "rim",
        "map" : "N/A"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.qualityFollowUp.remarks",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.qualityFollowUp.remarks",
      "short" : "Remarks or concerns about patient registration, data sharing, hospital communication, material availability, or other transmural collaboration aspects (SNOMED 276238005)",
      "definition" : "Remarks or concerns about patient registration, data sharing, hospital communication, material availability, or other transmural collaboration aspects (SNOMED 276238005)",
      "min" : 0,
      "max" : "1",
      "base" : {
        "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.qualityFollowUp.remarks",
        "min" : 0,
        "max" : "1"
      },
      "type" : [{
        "code" : "string"
      }]
    }]
  },
  "differential" : {
    "element" : [{
      "id" : "ONCOAzacitidineQuestionnaire",
      "path" : "ONCOAzacitidineQuestionnaire",
      "short" : "ONCO Azacitidine Questionnaire Logical Model",
      "definition" : "Logical model representing the nursing assessment questionnaire for home hospitalization patients receiving Azacitidine. This questionnaire is filled in by the home nurse during each visit and exchanged as a FHIR QuestionnaireResponse with the hospital. Specific features: includes oxygen saturation (conditional, only when cough or shortness of breath), contraindications focused on GI symptoms and general deterioration, and a medication dissolution check."
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment",
      "short" : "Nursing Assessment",
      "definition" : "Nursing Assessment",
      "min" : 1,
      "max" : "1",
      "type" : [{
        "code" : "BackboneElement"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.storage",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.storage",
      "short" : "Storage",
      "definition" : "Storage",
      "min" : 1,
      "max" : "1",
      "type" : [{
        "code" : "BackboneElement"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.storage.medicationStorageRemarks",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.storage.medicationStorageRemarks",
      "short" : "Are there any remarks or concerns regarding the (proper) home storage of medication? (SNOMED 422413002) | Answers: 710977001 Medication stored correctly | 424363005 Concern about proper home storage",
      "definition" : "Are there any remarks or concerns regarding the (proper) home storage of medication? (SNOMED 422413002) | Answers: 710977001 Medication stored correctly | 424363005 Concern about proper home storage",
      "min" : 1,
      "max" : "1",
      "type" : [{
        "code" : "code"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.storage.storageRemarksSpecification",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.storage.storageRemarksSpecification",
      "short" : "Specify remarks or concerns (conditional: if medicationStorageRemarks = concern)",
      "definition" : "Specify remarks or concerns (conditional: if medicationStorageRemarks = concern)",
      "min" : 0,
      "max" : "1",
      "type" : [{
        "code" : "string"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.observationParameters",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.observationParameters",
      "short" : "Observation Parameters",
      "definition" : "Observation Parameters",
      "min" : 1,
      "max" : "1",
      "type" : [{
        "code" : "BackboneElement"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.observationParameters.bodyTemperature",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.observationParameters.bodyTemperature",
      "short" : "Body temperature (°C) (LOINC 8310-5)",
      "definition" : "Body temperature (°C) (LOINC 8310-5)",
      "min" : 1,
      "max" : "1",
      "type" : [{
        "code" : "decimal"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.observationParameters.pulse",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.observationParameters.pulse",
      "short" : "Pulse (beats/min) (SNOMED 364075005)",
      "definition" : "Pulse (beats/min) (SNOMED 364075005)",
      "min" : 1,
      "max" : "1",
      "type" : [{
        "code" : "decimal"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.observationParameters.bloodPressureSystolic",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.observationParameters.bloodPressureSystolic",
      "short" : "Blood pressure systolic (mmHg) (LOINC 8480-6)",
      "definition" : "Blood pressure systolic (mmHg) (LOINC 8480-6)",
      "min" : 1,
      "max" : "1",
      "type" : [{
        "code" : "decimal"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.observationParameters.bloodPressureDiastolic",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.observationParameters.bloodPressureDiastolic",
      "short" : "Blood pressure diastolic (mmHg) (LOINC 8462-4)",
      "definition" : "Blood pressure diastolic (mmHg) (LOINC 8462-4)",
      "min" : 1,
      "max" : "1",
      "type" : [{
        "code" : "decimal"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.observationParameters.oxygenSaturation",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.observationParameters.oxygenSaturation",
      "short" : "Oxygen saturation (%) (LOINC 2708-6) — Only measure if cough or shortness of breath is present",
      "definition" : "Oxygen saturation (%) (LOINC 2708-6) — Only measure if cough or shortness of breath is present",
      "min" : 0,
      "max" : "1",
      "type" : [{
        "code" : "decimal"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications",
      "short" : "Contraindications",
      "definition" : "Contraindications",
      "min" : 1,
      "max" : "1",
      "type" : [{
        "code" : "BackboneElement"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.anyContraindication",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.anyContraindication",
      "short" : "Are there contraindications for administration? (SNOMED 395008009) | Answers: 373066001 Yes | 373067005 No",
      "definition" : "Are there contraindications for administration? (SNOMED 395008009) | Answers: 373066001 Yes | 373067005 No",
      "min" : 1,
      "max" : "1",
      "type" : [{
        "code" : "code"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.feverChillsUnwell",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.feverChillsUnwell",
      "short" : "Fever, chills, feeling unwell (SNOMED 39104002) | Answers: 373066001 Yes | 373067005 No (conditional: if anyContraindication = Yes)",
      "definition" : "Fever, chills, feeling unwell (SNOMED 39104002) | Answers: 373066001 Yes | 373067005 No (conditional: if anyContraindication = Yes)",
      "min" : 0,
      "max" : "1",
      "type" : [{
        "code" : "code"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.noOralIntake",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.noOralIntake",
      "short" : "No oral intake due to reduced appetite or taste changes (SNOMED 247318005) | Answers: 373066001 Yes | 373067005 No",
      "definition" : "No oral intake due to reduced appetite or taste changes (SNOMED 247318005) | Answers: 373066001 Yes | 373067005 No",
      "min" : 0,
      "max" : "1",
      "type" : [{
        "code" : "code"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.severeNausea",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.severeNausea",
      "short" : "Severe nausea (nausea with insufficient oral intake) (SNOMED 73335002) | Answers: 373066001 Yes | 373067005 No",
      "definition" : "Severe nausea (nausea with insufficient oral intake) (SNOMED 73335002) | Answers: 373066001 Yes | 373067005 No",
      "min" : 0,
      "max" : "1",
      "type" : [{
        "code" : "code"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.increasedDyspnea",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.increasedDyspnea",
      "short" : "Increased or severe shortness of breath (at rest or impacting daily activities) (SNOMED 297216006) | Answers: 373066001 Yes | 373067005 No",
      "definition" : "Increased or severe shortness of breath (at rest or impacting daily activities) (SNOMED 297216006) | Answers: 373066001 Yes | 373067005 No",
      "min" : 0,
      "max" : "1",
      "type" : [{
        "code" : "code"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.newOrIncreasedCough",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.newOrIncreasedCough",
      "short" : "New or increased productive/dry cough, with or without dyspnea (SNOMED 11833005) | Answers: 373066001 Yes | 373067005 No",
      "definition" : "New or increased productive/dry cough, with or without dyspnea (SNOMED 11833005) | Answers: 373066001 Yes | 373067005 No",
      "min" : 0,
      "max" : "1",
      "type" : [{
        "code" : "code"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.generalDeterioration",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.generalDeterioration",
      "short" : "General deterioration (SNOMED 154091000119106) | Answers: 373066001 Yes | 373067005 No",
      "definition" : "General deterioration (SNOMED 154091000119106) | Answers: 373066001 Yes | 373067005 No",
      "min" : 0,
      "max" : "1",
      "type" : [{
        "code" : "code"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.decisionAfterConsultation",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.decisionAfterConsultation",
      "short" : "Decision after consultation with hospital (SNOMED 182836005) | Answers: Administration | No administration | Other",
      "definition" : "Decision after consultation with hospital (SNOMED 182836005) | Answers: Administration | No administration | Other",
      "min" : 0,
      "max" : "1",
      "type" : [{
        "code" : "code"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.decisionOtherSpecification",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.contraindications.decisionOtherSpecification",
      "short" : "Specify if decision = Other (SNOMED 438833006)",
      "definition" : "Specify if decision = Other (SNOMED 438833006)",
      "min" : 0,
      "max" : "1",
      "type" : [{
        "code" : "string"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden",
      "short" : "Symptom Burden",
      "definition" : "Symptom Burden",
      "min" : 1,
      "max" : "1",
      "type" : [{
        "code" : "BackboneElement"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.nausea",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.nausea",
      "short" : "Nausea (SNOMED 422587007) | Answers: 444431007 Grade 0 (None) | 444456001 Grade 1 | 444457005 Grade 2 | 444447009 Grade 3",
      "definition" : "Nausea (SNOMED 422587007) | Answers: 444431007 Grade 0 (None) | 444456001 Grade 1 | 444457005 Grade 2 | 444447009 Grade 3",
      "min" : 1,
      "max" : "1",
      "type" : [{
        "code" : "code"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.vomiting",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.vomiting",
      "short" : "Vomiting (SNOMED 249497008) | Answers: 444431007 Grade 0 | 444456001 Grade 1 (<=2 times) | 444457005 Grade 2 (3-5 times) | 444447009 Grade 3 (6+ times)",
      "definition" : "Vomiting (SNOMED 249497008) | Answers: 444431007 Grade 0 | 444456001 Grade 1 (<=2 times) | 444457005 Grade 2 (3-5 times) | 444447009 Grade 3 (6+ times)",
      "min" : 1,
      "max" : "1",
      "type" : [{
        "code" : "code"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.reducedAppetiteOrTasteChanges",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.reducedAppetiteOrTasteChanges",
      "short" : "Reduced appetite or taste changes (SNOMED 64379006) | Answers: 444431007 Grade 0 | 444456001 Grade 1 | 444457005 Grade 2 | 444447009 Grade 3",
      "definition" : "Reduced appetite or taste changes (SNOMED 64379006) | Answers: 444431007 Grade 0 | 444456001 Grade 1 | 444457005 Grade 2 | 444447009 Grade 3",
      "min" : 1,
      "max" : "1",
      "type" : [{
        "code" : "code"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.diarrhea",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.diarrhea",
      "short" : "Diarrhea (SNOMED 62315008) | Answers: 444431007 Grade 0 | 444456001 Grade 1 (1-3x more) | 444457005 Grade 2 (4-6x more) | 444447009 Grade 3 (>6x or impacting daily life)",
      "definition" : "Diarrhea (SNOMED 62315008) | Answers: 444431007 Grade 0 | 444456001 Grade 1 (1-3x more) | 444457005 Grade 2 (4-6x more) | 444447009 Grade 3 (>6x or impacting daily life)",
      "min" : 1,
      "max" : "1",
      "type" : [{
        "code" : "code"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.constipation",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.constipation",
      "short" : "Constipation (SNOMED 14760008) | Answers: 444431007 Grade 0 | 444456001 Grade 1 | 444457005 Grade 2 | 444447009 Grade 3",
      "definition" : "Constipation (SNOMED 14760008) | Answers: 444431007 Grade 0 | 444456001 Grade 1 | 444457005 Grade 2 | 444447009 Grade 3",
      "min" : 1,
      "max" : "1",
      "type" : [{
        "code" : "code"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.fatigue",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.fatigue",
      "short" : "Fatigue / lack of energy (SNOMED 224960004) | Answers: 444431007 Grade 0 | 444456001 Grade 1 (mild) | 444457005 Grade 2 (moderate) | 444447009 Grade 3 (severe)",
      "definition" : "Fatigue / lack of energy (SNOMED 224960004) | Answers: 444431007 Grade 0 | 444456001 Grade 1 (mild) | 444457005 Grade 2 (moderate) | 444447009 Grade 3 (severe)",
      "min" : 1,
      "max" : "1",
      "type" : [{
        "code" : "code"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.pain",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.pain",
      "short" : "Pain (SNOMED 112104007) | Answers: 444431007 Grade 0 | 444456001 Grade 1 (mild) | 444457005 Grade 2 (moderate) | 444447009 Grade 3 (severe)",
      "definition" : "Pain (SNOMED 112104007) | Answers: 444431007 Grade 0 | 444456001 Grade 1 (mild) | 444457005 Grade 2 (moderate) | 444447009 Grade 3 (severe)",
      "min" : 1,
      "max" : "1",
      "type" : [{
        "code" : "code"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.skinRash",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.skinRash",
      "short" : "Skin rash (SNOMED 271807003) | Answers: 444431007 Grade 0 | 444456001 Grade 1 (limited redness) | 444457005 Grade 2 (moderate redness) | 444447009 Grade 3 (severe/extensive redness or peeling)",
      "definition" : "Skin rash (SNOMED 271807003) | Answers: 444431007 Grade 0 | 444456001 Grade 1 (limited redness) | 444457005 Grade 2 (moderate redness) | 444447009 Grade 3 (severe/extensive redness or peeling)",
      "min" : 1,
      "max" : "1",
      "type" : [{
        "code" : "code"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.psychosocialBurden",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.psychosocialBurden",
      "short" : "Psychosocial burden (SNOMED 384821006) | Answers: 444431007 Grade 0 (Feels well) | 444456001 Grade 1 (mild distress) | 444457005 Grade 2 (moderate impact) | 444447009 Grade 3 (severe impact)",
      "definition" : "Psychosocial burden (SNOMED 384821006) | Answers: 444431007 Grade 0 (Feels well) | 444456001 Grade 1 (mild distress) | 444457005 Grade 2 (moderate impact) | 444447009 Grade 3 (severe impact)",
      "min" : 1,
      "max" : "1",
      "type" : [{
        "code" : "code"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.shortnessOfBreath",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.shortnessOfBreath",
      "short" : "Shortness of breath (SNOMED 267036007) | Answers: 444431007 Grade 0 | 444456001 Grade 1 (moderate exertion only) | 444457005 Grade 2 (light exertion affecting daily activities) | 444447009 Grade 3 (at rest affecting daily activities)",
      "definition" : "Shortness of breath (SNOMED 267036007) | Answers: 444431007 Grade 0 | 444456001 Grade 1 (moderate exertion only) | 444457005 Grade 2 (light exertion affecting daily activities) | 444447009 Grade 3 (at rest affecting daily activities)",
      "min" : 1,
      "max" : "1",
      "type" : [{
        "code" : "code"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.cough",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.symptomBurden.cough",
      "short" : "Cough (SNOMED 49727002) | Answers: 444431007 Grade 0 | 444456001 Grade 1 (mild) | 444457005 Grade 2 (moderate) | 444447009 Grade 3 (severe)",
      "definition" : "Cough (SNOMED 49727002) | Answers: 444431007 Grade 0 | 444456001 Grade 1 (mild) | 444457005 Grade 2 (moderate) | 444447009 Grade 3 (severe)",
      "min" : 1,
      "max" : "1",
      "type" : [{
        "code" : "code"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.otherRelevantObservations",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.otherRelevantObservations",
      "short" : "Other Relevant Observations",
      "definition" : "Other Relevant Observations",
      "min" : 0,
      "max" : "1",
      "type" : [{
        "code" : "BackboneElement"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.otherRelevantObservations.otherObservations",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.otherRelevantObservations.otherObservations",
      "short" : "Other side effects or relevant clinical and psychosocial observations. Contact hospital in case of clinical concern. (SNOMED 365275006)",
      "definition" : "Other side effects or relevant clinical and psychosocial observations. Contact hospital in case of clinical concern. (SNOMED 365275006)",
      "min" : 0,
      "max" : "1",
      "type" : [{
        "code" : "string"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.task",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.task",
      "short" : "Task",
      "definition" : "Task",
      "min" : 1,
      "max" : "1",
      "type" : [{
        "code" : "BackboneElement"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.task.medicationDissolvedClear",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.task.medicationDissolvedClear",
      "short" : "Medication was completely dissolved into a clear solution without visible particles (SNOMED 396076000) | Answers: 373066001 Yes | 373067005 No",
      "definition" : "Medication was completely dissolved into a clear solution without visible particles (SNOMED 396076000) | Answers: 373066001 Yes | 373067005 No",
      "min" : 1,
      "max" : "1",
      "type" : [{
        "code" : "code"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.task.medicationAdministeredPerProcedure",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.task.medicationAdministeredPerProcedure",
      "short" : "Could the medication be administered exactly according to the procedure (no deviations)? (SNOMED 373149000) | Answers: 373066001 Yes | 373067005 No",
      "definition" : "Could the medication be administered exactly according to the procedure (no deviations)? (SNOMED 373149000) | Answers: 373066001 Yes | 373067005 No",
      "min" : 1,
      "max" : "1",
      "type" : [{
        "code" : "code"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.qualityFollowUp",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.qualityFollowUp",
      "short" : "Quality Follow-Up",
      "definition" : "Quality Follow-Up",
      "min" : 0,
      "max" : "1",
      "type" : [{
        "code" : "BackboneElement"
      }]
    },
    {
      "id" : "ONCOAzacitidineQuestionnaire.nursingAssessment.qualityFollowUp.remarks",
      "path" : "ONCOAzacitidineQuestionnaire.nursingAssessment.qualityFollowUp.remarks",
      "short" : "Remarks or concerns about patient registration, data sharing, hospital communication, material availability, or other transmural collaboration aspects (SNOMED 276238005)",
      "definition" : "Remarks or concerns about patient registration, data sharing, hospital communication, material availability, or other transmural collaboration aspects (SNOMED 276238005)",
      "min" : 0,
      "max" : "1",
      "type" : [{
        "code" : "string"
      }]
    }]
  }
}